<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:cc="http://web.resource.org/cc/"
 xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.mdpi.com/rss/journal/ijms">
		<title>International Journal of Molecular Sciences</title>
		<link>http://www.mdpi.com/journal/ijms</link>
		<description>Latest open access articles published in Int. J. Mol. Sci. at http://www.mdpi.com/journal/ijms</description>
								<items>
			<rdf:Seq>
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12729" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12714" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12696" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12675" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12661" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12650" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12620" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12607" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12593" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12581" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12563" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12550" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12533" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12520" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12496" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12484" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12458" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12411" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12401" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12380" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12367" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12346" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12329" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12313" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12297" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12273" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12249" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12222" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12205" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12186" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12170" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12157" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12138" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12123" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12107" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12090" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12073" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12054" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12037" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12023" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12013" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/12004" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11994" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11981" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11963" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11942" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11929" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11915" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11895" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11871" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11861" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11842" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11830" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11816" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11795" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11767" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11742" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11713" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11692" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11643" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11626" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11607" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11560" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11544" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11527" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11510" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11496" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11484" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11444" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11438" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11424" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11402" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11392" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11376" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11356" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11347" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11319" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11302" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11277" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11259" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11238" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11224" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11208" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11190" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11171" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11157" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11145" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11125" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11113" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11096" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11084" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11072" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11061" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11034" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11024" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/11011" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/10998" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/10979" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/10958" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1422-0067/14/6/10944" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
	</channel>

        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12729">
	<title><![CDATA[IJMS, Vol. 14, Pages 12729-12763: Role of CBFs as Integrators of Chloroplast Redox, Phytochrome and Plant Hormone Signaling during Cold Acclimation]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12729</link>
	<description>Cold acclimation of winter cereals and other winter hardy species is a prerequisite to increase subsequent freezing tolerance. Low temperatures upregulate the expression of  C-repeat/dehydration-responsive element binding transcription factors (CBF/DREB1) which in turn induce the expression of COLD-REGULATED (COR) genes. We summarize evidence which indicates that the integration of these interactions is responsible for the dwarf phenotype and enhanced photosynthetic performance associated with cold-acclimated and CBF-overexpressing plants. Plants overexpressing CBFs but grown at warm temperatures mimic the cold-tolerant, dwarf, compact phenotype; increased photosynthetic performance; and biomass accumulation typically associated with cold-acclimated plants. In this review, we propose a model whereby the cold acclimation signal is perceived by plants through an integration of low temperature and changes in light intensity, as well as changes in light quality. Such integration leads to the activation of the CBF-regulon and subsequent upregulation of COR gene and GA 2-oxidase (GA2ox) expression which results in a dwarf phenotype coupled with increased freezing tolerance and enhanced photosynthetic performance. We conclude that, due to their photoautotrophic nature, plants do not rely on a single low temperature sensor, but integrate changes in light intensity, light quality, and membrane viscosity in order to establish the cold-acclimated state. CBFs appear to act as master regulators of these interconnecting sensing/signaling pathways.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-18</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612729</prism:doi>
	<prism:startingPage>12729</prism:startingPage>
		<prism:endingPage>12763</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Role of CBFs as Integrators of Chloroplast Redox, Phytochrome and Plant Hormone Signaling during Cold Acclimation]]></dc:title>
    <dc:date>2013-06-18</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612729</dc:identifier>
    	<dc:creator>Leonid Kurepin</dc:creator>
		<dc:creator>Keshav Dahal</dc:creator>
		<dc:creator>Leonid Savitch</dc:creator>
		<dc:creator>Jas Singh</dc:creator>
		<dc:creator>Rainer Bode</dc:creator>
		<dc:creator>Alexander Ivanov</dc:creator>
		<dc:creator>Vaughan Hurry</dc:creator>
		<dc:creator>Norman Hüner</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12714">
	<title><![CDATA[IJMS, Vol. 14, Pages 12714-12728: Dual Delivery of BMP-2 and bFGF from a New  Nano-Composite Scaffold, Loaded with Vascular Stents  for Large-Size Mandibular Defect Regeneration]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12714</link>
	<description>The aim of this study was to investigate the feasibility and advantages of the dual delivery of bone morphogenetic protein-2 (BMP-2) and basic fibroblast growth factor (bFGF) from nano-composite scaffolds (PLGA/PCL/nHA) loaded with vascular stents (PLCL/Col/nHA) for large bone defect regeneration in rabbit mandibles. Thirty-six large bone defects were repaired in rabbits using engineering bone composed of allogeneic bone marrow mesenchymal stem cells (BMSCs), bFGF, BMP-2 and scaffolds composed of PLGA/PCL/nHA loaded with PLCL/Col/nHA. The experiments were divided into six groups: BMSCs/bFGF/BMP-2/scaffold, BMSCs/BMP-2/scaffold, BMSCs/bFGF/scaffold, BMSCs/scaffold, scaffold alone and no treatment. Sodium alginate hydrogel was used as the carrier for BMP-2 and bFGF and its features, including gelling, degradation and controlled release properties, was detected by the determination of gelation and degradation time coupled with a controlled release study of bovine serum albumin (BSA). AlamarBlue assay and alkaline phosphatase (ALP) activity were used to evaluate the proliferation and osteogenic differentiation of BMSCs in different groups. X-ray and histological examinations of the samples were performed after 4 and 12 weeks  post-implantation to clarify new bone formation in the mandible defects. The results verified that the use of sodium alginate hydrogel as a controlled release carrier has good sustained release ability, and the combined application of bFGF and BMP-2 could significantly promote the proliferation and osteogenic differentiation of BMSCs (p &amp;amp;lt; 0.05 or p &amp;amp;lt; 0.01). In addition, X-ray and histological examinations of the samples exhibited that the dual release group had significantly higher bone formation than the other groups. The above results indicate that the delivery of both growth factors could enhance new bone formation and vascularization compared with delivery of BMP-2 or bFGF alone, and may supply a promising way of repairing large bone defects in bone tissue engineering.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-18</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612714</prism:doi>
	<prism:startingPage>12714</prism:startingPage>
		<prism:endingPage>12728</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Dual Delivery of BMP-2 and bFGF from a New  Nano-Composite Scaffold, Loaded with Vascular Stents  for Large-Size Mandibular Defect Regeneration]]></dc:title>
    <dc:date>2013-06-18</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612714</dc:identifier>
    	<dc:creator>Jiansheng Su</dc:creator>
		<dc:creator>Hongzhen Xu</dc:creator>
		<dc:creator>Jun Sun</dc:creator>
		<dc:creator>Xue Gong</dc:creator>
		<dc:creator>Hang Zhao</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12696">
	<title><![CDATA[IJMS, Vol. 14, Pages 12696-12713: Potential Mechanisms Linking Atherosclerosis and Increased Cardiovascular Risk in COPD: Focus On Sirtuins]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12696</link>
	<description>The development of atherosclerosis is a multi-step process, at least in part controlled by the vascular endothelium function. Observations in humans and experimental models of atherosclerosis have identified monocyte recruitment as an early event in atherogenesis. Chronic inflammation is associated with ageing and its related diseases (e.g., atherosclerosis and chronic obstructive pulmonary disease). Recently it has been discovered that Sirtuins (NAD+-dependent deacetylases) represent a pivotal regulator of longevity and health. They appear to have a prominent role in vascular biology and regulate aspects of age-dependent atherosclerosis. Many studies demonstrate that SIRT1 exhibits anti-inflammatory properties in vitro (e.g., fatty acid-induced inflammation),  in vivo (e.g., atherosclerosis, sustainment of normal immune function in knock-out mice) and in clinical studies (e.g., patients with chronic obstructive pulmonary disease). Because of a significant reduction of SIRT1 in rodent lungs exposed to cigarette smoke and in lungs of patients with chronic obstructive pulmonary disease (COPD), activation of SIRT1 may be a potential target for chronic obstructive pulmonary disease therapy. We review the inflammatory mechanisms involved in COPD-CVD coexistence and the potential role of SIRT1 in the regulation of these systems.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-17</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612696</prism:doi>
	<prism:startingPage>12696</prism:startingPage>
		<prism:endingPage>12713</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Potential Mechanisms Linking Atherosclerosis and Increased Cardiovascular Risk in COPD: Focus On Sirtuins]]></dc:title>
    <dc:date>2013-06-17</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612696</dc:identifier>
    	<dc:creator>Graziamaria Corbi</dc:creator>
		<dc:creator>Andrea Bianco</dc:creator>
		<dc:creator>Viviana Turchiarelli</dc:creator>
		<dc:creator>Michele Cellurale</dc:creator>
		<dc:creator>Federica Fatica</dc:creator>
		<dc:creator>Aurora Daniele</dc:creator>
		<dc:creator>Gennaro Mazzarella</dc:creator>
		<dc:creator>Nicola Ferrara</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12675">
	<title><![CDATA[IJMS, Vol. 14, Pages 12675-12695: Tracking the Interplay between Bound Peptide and the Lid Domain of DnaK, Using Molecular Dynamics]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12675</link>
	<description>Hsp70 chaperones consist of two functional domains: the 44 kDa Nucleotide Binding Domain (NBD), that binds and hydrolyses ATP, and the 26 kDa Substrate Binding Domain (SBD), which binds unfolded proteins and reactivates them, utilizing energy obtained from nucleotide hydrolysis. The structure of the SBD of the bacterial Hsp70, DnaK, consists of two sub-domains: A β-sandwich part containing the hydrophobic cavity to which the hepta-peptide NRLLLTG (NR) is bound, and a segment made of 5 α-helices, called the “lid” that caps the top of the β-sandwich domain. In the present study we used the Escherichia coli Hsp70, DnaK, as a model for Hsp70 proteins, focusing on its SBD domain, examining the changes in the lid conformation. We deliberately decoupled the NBD from the SBD, limiting the study to the structure of the SBD section, with an emphasis on the interaction between the charges of the peptide with the residues located in the lid. Molecular dynamics simulations of the complex revealed significant mobility within the lid structure; as the structure was released from the forces operating during the crystallization process, the two terminal helices established a contact with the positive charge at the tip of the peptide. This contact is manifested only in the presence of electrostatic attraction. The observed internal motions within the lid provide a molecular role for the function of this sub-domain during the reaction cycle of Hsp 70 chaperones.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-17</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612675</prism:doi>
	<prism:startingPage>12675</prism:startingPage>
		<prism:endingPage>12695</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Tracking the Interplay between Bound Peptide and the Lid Domain of DnaK, Using Molecular Dynamics]]></dc:title>
    <dc:date>2013-06-17</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612675</dc:identifier>
    	<dc:creator>Itzhaq Azoulay</dc:creator>
		<dc:creator>Nataly Kucherenko</dc:creator>
		<dc:creator>Esther Nachliel</dc:creator>
		<dc:creator>Menachem Gutman</dc:creator>
		<dc:creator>Abdussalam Azem</dc:creator>
		<dc:creator>Yossi Tsfadia</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12661">
	<title><![CDATA[IJMS, Vol. 14, Pages 12661-12674: Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12661</link>
	<description>Over expressing in PTPN1 (encoding Protein tyrosine phosphatase 1B, PTP1B), a protein tyrosine phosphatase (PTP) that plays an overall positive role in insulin signaling, is linked to the pathogenesis of diabetes and obesity. The relationship between PTP1B and human diseases exhibits PTP1B as the target to treat these diseases. In this article, small weight molecules of the imidazolidine series were screened from databases and optimized on silicon as the inhibitors of PTP1B based on the steric conformation and electronic configuration of thiazolidinedione (TZD) compounds. The top three candidates were tested using an in vitro biological assay after synthesis. Finally, we report a novel inhibitor, Compound 13, that specifically inhibits PTP1B over the closely related phosphatase Src homology 2 (SH2) domain-containing phosphatase 2 (SHP-2) at 80 μΜ. Its IC50 values are reported in this paper as well. This compound was further verified by computer analysis for its ability to combine the catalytic domains of PTP1B and SHP-2 by molecular dynamics (MD) simulations.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-17</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612661</prism:doi>
	<prism:startingPage>12661</prism:startingPage>
		<prism:endingPage>12674</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2]]></dc:title>
    <dc:date>2013-06-17</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612661</dc:identifier>
    	<dc:creator>Su-Xia Sun</dc:creator>
		<dc:creator>Xiao-Bo Li</dc:creator>
		<dc:creator>Wen-Bo Liu</dc:creator>
		<dc:creator>Ying Ma</dc:creator>
		<dc:creator>Run-Ling Wang</dc:creator>
		<dc:creator>Xian-Chao Cheng</dc:creator>
		<dc:creator>Shu-Qing Wang</dc:creator>
		<dc:creator>Wei Liu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12650">
	<title><![CDATA[IJMS, Vol. 14, Pages 12650-12660: Human Chorionic Gonadotropin Beta Subunit Genes CGB1 and CGB2 are Transcriptionally Active in Ovarian Cancer]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12650</link>
	<description>Human chorionic gonadotropin beta subunit (CGB) is a marker of pregnancy as well as trophoblastic and nontrophoblastic tumors. CGB is encoded by a cluster of six genes, of which type II genes (CGB3/9, 5 and 8) have been shown to be upregulated in relation to type I genes (CGB6/7) in both placentas and tumors. Recent studies revealed that CGB1 and CGB2, originally considered as pseudogenes, might also be active, however, the protein products of these genes have not yet been identified. Our study demonstrates the presence of CGB1 and CGB2 transcripts in ovarian carcinomas. While CGB1 and CGB2 gene activation was not detected in normal ovaries lacking cancerous development, our study demonstrates the presence of CGB1 and CGB2 transcripts in 41% of analyzed ovarian cancer cases.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-17</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612650</prism:doi>
	<prism:startingPage>12650</prism:startingPage>
		<prism:endingPage>12660</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Human Chorionic Gonadotropin Beta Subunit Genes CGB1 and CGB2 are Transcriptionally Active in Ovarian Cancer]]></dc:title>
    <dc:date>2013-06-17</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612650</dc:identifier>
    	<dc:creator>Marta Kubiczak</dc:creator>
		<dc:creator>Grzegorz Walkowiak</dc:creator>
		<dc:creator>Ewa Nowak-Markwitz</dc:creator>
		<dc:creator>Anna Jankowska</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12620">
	<title><![CDATA[IJMS, Vol. 14, Pages 12620-12649: The Present and Future of Prostate Cancer Urine Biomarkers]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12620</link>
	<description>In order to successfully cure patients with prostate cancer (PCa), it is important to detect the disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they cannot specifically differentiate between those patients who should be treated immediately and those who should avoid over-treatment. Current screening  techniques lack specificity, and a decisive diagnosis of PCa is based on prostate biopsy. Although PCa screening is widely utilized nowadays, two thirds of the biopsies performed are still unnecessary. Thus the discovery of non-invasive PCa biomarkers remains urgent. In recent years, the utilization of urine has emerged as an attractive option for the  non-invasive detection of PCa. Moreover, a great improvement in high-throughput “omic” techniques has presented considerable opportunities for the identification of new biomarkers. Herein, we will review the most significant urine biomarkers described in recent years, as well as some future prospects in that field.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-17</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612620</prism:doi>
	<prism:startingPage>12620</prism:startingPage>
		<prism:endingPage>12649</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[The Present and Future of Prostate Cancer Urine Biomarkers]]></dc:title>
    <dc:date>2013-06-17</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612620</dc:identifier>
    	<dc:creator>Marina Rigau</dc:creator>
		<dc:creator>Mireia Olivan</dc:creator>
		<dc:creator>Marta Garcia</dc:creator>
		<dc:creator>Tamara Sequeiros</dc:creator>
		<dc:creator>Melania Montes</dc:creator>
		<dc:creator>Eva Colás</dc:creator>
		<dc:creator>Marta Llauradó</dc:creator>
		<dc:creator>Jacques Planas</dc:creator>
		<dc:creator>Inés Torres</dc:creator>
		<dc:creator>Juan Morote</dc:creator>
		<dc:creator>Colin Cooper</dc:creator>
		<dc:creator>Jaume Reventós</dc:creator>
		<dc:creator>Jeremy Clark</dc:creator>
		<dc:creator>Andreas Doll</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12607">
	<title><![CDATA[IJMS, Vol. 14, Pages 12607-12619: Quorum Sensing and Phytochemicals]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12607</link>
	<description>Most infectious diseases are caused by bacteria, which proliferate within quorum sensing (QS)-mediated biofilms. Efforts to block QS in bacteria and disrupt biofilms have enabled the identification of bioactive molecules that are also produced by plants. This mini review primarily focuses on natural QS inhibitors, which display potential for treating bacterial infections and also enhance the safety of food supply.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-17</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612607</prism:doi>
	<prism:startingPage>12607</prism:startingPage>
		<prism:endingPage>12619</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Quorum Sensing and Phytochemicals]]></dc:title>
    <dc:date>2013-06-17</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612607</dc:identifier>
    	<dc:creator>Filomena Nazzaro</dc:creator>
		<dc:creator>Florinda Fratianni</dc:creator>
		<dc:creator>Raffaele Coppola</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12593">
	<title><![CDATA[IJMS, Vol. 14, Pages 12593-12606: Effect of Dietary Cholesterol and Cholesterol Oxides on  Blood Cholesterol, Lipids, and the Development of Atherosclerosis in Rabbits]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12593</link>
	<description>Two studies were conducted to determine the effects of dietary cholesterol (CHO) and cholesterol oxides (COPs) on the development of atherosclerosis and the changes in fatty acid and blood characteristics in rabbits. In the first study, forty male New Zealand white rabbits were divided into 5 groups and fed commercial rabbit chow with no added CHO or COPs, 1 g CHO, 0.9 g CHO + 0.1 g COPs, 0.8 g CHO + 0.2 g COPs, or  0.5 g CHO + 0.5 g COPs per kg diet. In the second study, 24 male New Zealand White rabbits were divided into 3 groups and fed a diet containing 2 g CHO, 1.6 g CHO + 0.4 g COPs, or 1.2 g CHO + 0.8 g COPs per kg diet. All diets induced atherosclerotic lesions in the rabbits’ ascending thoracic aorta. The serum CHO and triglyceride levels (p &amp;amp;lt; 0.05) increased significantly with the increased levels of CHO in the diets. Dietary CHO or COPs did not influence high-density lipoprotein CHO levels. The ratio of saturated fatty acid to unsaturated fatty acid increased as the level of dietary CHO and COPs increased.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-17</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612593</prism:doi>
	<prism:startingPage>12593</prism:startingPage>
		<prism:endingPage>12606</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Effect of Dietary Cholesterol and Cholesterol Oxides on  Blood Cholesterol, Lipids, and the Development of Atherosclerosis in Rabbits]]></dc:title>
    <dc:date>2013-06-17</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612593</dc:identifier>
    	<dc:creator>Sun Hur</dc:creator>
		<dc:creator>Byungrok Min</dc:creator>
		<dc:creator>Ki Nam</dc:creator>
		<dc:creator>Eun Lee</dc:creator>
		<dc:creator>Dong Ahn</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12581">
	<title><![CDATA[IJMS, Vol. 14, Pages 12581-12592: Anti-Inflammatory Components from the Root of  Solanum erianthum]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12581</link>
	<description>Two new norsesquiterpenoids, solanerianones A and B (1–2), together with nine known compounds, including four sesquiterpenoids, (−)-solavetivone (3), (+)-anhydro-β-rotunol (4), solafuranone (5), lycifuranone A (6); one alkaloid, N-trans-feruloyltyramine (7); one fatty acid, palmitic acid (8); one phenylalkanoid, acetovanillone (9), and two steroids, β-sitosterol (10) and stigmasterol (11) were isolated from the n-hexane-soluble part of the roots of Solanum erianthum. Their structures were elucidated on the basis of physical and spectroscopic data analyses. The anti-inflammatory activity of these isolates was monitored by nitric oxide (NO) production in lipopolysaccharide (LPS)-activated murine macrophage RAW264.7 cells. The cytotoxicity towards human lung squamous carcinoma (CH27), human hepatocellular carcinoma (Hep 3B), human oral squamous carcinoma (HSC-3) and human melanoma (M21) cell lines was also screened by using an MTT assay. Of the compounds tested, 3 exhibited the strongest NO inhibition with the average maximum inhibition (Emax) at 100 μM and median inhibitory concentration (IC50) values of 98.23% ± 0.08% and 65.54 ± 0.18 μM, respectively. None of compounds (1–9) was found to possess cytotoxic activity against human cancer cell lines at concentrations up to 30 μM.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-14</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612581</prism:doi>
	<prism:startingPage>12581</prism:startingPage>
		<prism:endingPage>12592</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Anti-Inflammatory Components from the Root of  Solanum erianthum]]></dc:title>
    <dc:date>2013-06-14</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612581</dc:identifier>
    	<dc:creator>Yu-Chang Chen</dc:creator>
		<dc:creator>Hong-Zin Lee</dc:creator>
		<dc:creator>Hsin-Chun Chen</dc:creator>
		<dc:creator>Chi-Luan Wen</dc:creator>
		<dc:creator>Yueh-Hsiung Kuo</dc:creator>
		<dc:creator>Guei-Jane Wang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12563">
	<title><![CDATA[IJMS, Vol. 14, Pages 12563-12580: Glycyrrhizin Represses Total Parenteral Nutrition-Associated Acute Liver Injury in Rats by Suppressing Endoplasmic Reticulum Stress]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12563</link>
	<description>Total parenteral nutrition (TPN) is an artificial way to support daily nutritional requirements by bypassing the digestive system, but long-term TPN administration may cause severe liver dysfunction. Glycyrrhizin is an active component of licorice root that has been widely used to treat chronic hepatitis. The aim of this study is to investigate the hepatoprotective effect of glycyrrhizin on TPN-associated acute liver injury in vivo. Liver dysfunction was induced by intravenous infusion of TPN at a flow rate of 20 mL/kg/h for three h in Sprague Dawley rats. The rats were pretreated with Glycyrrhizin (1, 3 and  10 mg/kg intravenously). After receiving TPN or saline (control group) for three h, the rats were sacrificed, blood samples were collected for biochemical analyses and liver tissue was removed for histopathological and immunohistochemical examination. We found that aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TB) and triglyceride (TG) levels were significantly increased in the TPN group without glycyrrhizin pretreatment and decreased in the glycyrrhizin-pretreated TPN group in a dose-dependent manner. The stained liver sections showed that glycyrrhizin relieved acute liver injury. The upregulation of serum protein biomarkers of reactive nitrogen species, including nitrotyrosine and inducible NO synthase (iNOS), were attenuated by glycyrrhizin pretreatment. Levels of endoplasmic reticulum (ER) stress factors, such as phosphorylation of JNK1/2, p38 MAPK and CHOP, were decreased by glycyrrhizin pretreatment. In summary, our results suggest that glycyrrhizin decreases TPN-associated acute liver injury factors by suppressing endoplasmic reticulum stress and reactive nitrogen stress.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-14</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612563</prism:doi>
	<prism:startingPage>12563</prism:startingPage>
		<prism:endingPage>12580</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Glycyrrhizin Represses Total Parenteral Nutrition-Associated Acute Liver Injury in Rats by Suppressing Endoplasmic Reticulum Stress]]></dc:title>
    <dc:date>2013-06-14</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612563</dc:identifier>
    	<dc:creator>Jai-Jen Tsai</dc:creator>
		<dc:creator>Hsing-Chun Kuo</dc:creator>
		<dc:creator>Kam-Fai Lee</dc:creator>
		<dc:creator>Tung-Hu Tsai</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12550">
	<title><![CDATA[IJMS, Vol. 14, Pages 12550-12562: Does Melatonin Homeostasis Play a Role in Continuous Epigastric Pain Syndrome?]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12550</link>
	<description>Two clinical forms of functional dyspepsia (FD) are listed in the Rome III criteria: postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS), differing in the recurrence of ailments depending on the diet. Continuous EPS (CEPS) is observed in some EPS patients, also at night, but its cause is still unknown. We showed previously that melatonin (MEL) homeostasis may be associated with FD. In the present work we evaluated selected components of melatonin homeostasis in patients with CEPS. The study included 30 patients with CEPS, 21 women and nine men, aged 21–49 years and  30 control subjects (EPS excluded); organic and mental diseases, as well as Helicobacter pylori infection, were excluded in both groups. The average severity of abdominal pain in the last three months was estimated in a 10-point scale (Visual Analog Scale). The levels of mRNA expression of arylalkylamine-N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT), the main components of MEL homeostasis, were determined in gastric mucosa with real time PCR. The fasting serum level of MEL (at 09:00 a.m.) and circadian urine excretion of 6-sulfatoxymelatonin (6-HMS) were determined with ELISA. AANAT expression in antral mucosa of control subjects was 1.76 ± 0.41, in the gastric body 1.35 ± 0.38, and in the dyspeptic group 1.42 ± 0.38 (p &amp;amp;lt; 0.05) and 0.92 ± 0.55  (p &amp;amp;lt; 0.05), respectively. HIOMT expression in the control was 2.05 ± 0.70 in the antrum and 1.57 ± 0.69 in the body and in the CEPS group, it was: 1.51 ± 0.57 (p &amp;amp;lt; 0.05) and  0.74 ± 0.31 (p &amp;amp;lt; 0.001), respectively. MEL concentration (pg/mL) was 9.41 ± 3.09 in the control group and 5.62 ± 1.34 (p &amp;amp;lt; 0.01) in the CEPS group. Urinary 6-HMS excretion (μg/24 h) was 11.40 ± 4.46 in the controls and 7.68 ± 2.88 (p &amp;amp;lt; 0.05) in the CEPS. Moreover, a negative correlation was found between the tested parameters and severity of epigastric pain. These results indicate that patients with CEPS may display low level of AANAT and HIOMT expression in gastric mucosa, resulting in decreased MEL synthesis.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-14</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612550</prism:doi>
	<prism:startingPage>12550</prism:startingPage>
		<prism:endingPage>12562</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Does Melatonin Homeostasis Play a Role in Continuous Epigastric Pain Syndrome?]]></dc:title>
    <dc:date>2013-06-14</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612550</dc:identifier>
    	<dc:creator>Cezary Chojnacki</dc:creator>
		<dc:creator>Tomasz Poplawski</dc:creator>
		<dc:creator>Janusz Blasiak</dc:creator>
		<dc:creator>Jan Chojnacki</dc:creator>
		<dc:creator>Grazyna Klupinska</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12533">
	<title><![CDATA[IJMS, Vol. 14, Pages 12533-12549: Metabolomic-Based Study of the Leafy Gall, the Ecological Niche of the Phytopathogen Rhodococcus Fascians,  as a Potential Source of Bioactive Compounds]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12533</link>
	<description>Leafy gall is a plant hyperplasia induced upon Rhodococcus fascians infection. Previously, by genomic and transcriptomic analysis, it has been reported that, at the early stage of symptom development, both primary and secondary metabolisms are modified. The present study is based on the hypothesis that fully developed leafy gall, could represent a potential source of new bioactive compounds. Therefore, non-targeted metabolomic analysis of aqueous and chloroform extracts of leafy gall and non-infected tobacco was carried out by 1H-NMR coupled to principal component analysis (PCA) and orthogonal projections to latent structures-discriminant analysis (OPLS-DA). Polar metabolite profiling reflects modifications mainly in the primary metabolites and in some polyphenolics. In contrast, main modifications occurring in non-polar metabolites concern secondary metabolites, and gas chromatography and mass spectrometry (GC-MS) evidenced alterations in diterpenoids family. Analysis of crude extracts of leafy galls and non-infected tobacco leaves exhibited a distinct antiproliferative activity against all four tested human cancer cell lines. A bio-guided fractionation of chloroformic crude extract yield to semi-purified fractions, which inhibited proliferation of glioblastoma U373 cells with IC50 between 14.0 and 2.4 µg/mL. Discussion is focused on the consequence of these metabolic changes, with respect to plant defense mechanisms following infection. Considering the promising role of diterpenoid family as bioactive compounds, leafy gall may rather be a propitious source for drug discovery.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-14</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612533</prism:doi>
	<prism:startingPage>12533</prism:startingPage>
		<prism:endingPage>12549</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Metabolomic-Based Study of the Leafy Gall, the Ecological Niche of the Phytopathogen Rhodococcus Fascians,  as a Potential Source of Bioactive Compounds]]></dc:title>
    <dc:date>2013-06-14</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612533</dc:identifier>
    	<dc:creator>Aminata Nacoulma</dc:creator>
		<dc:creator>Olivier Vandeputte</dc:creator>
		<dc:creator>Manuella De Lorenzi</dc:creator>
		<dc:creator>Mondher Jaziri</dc:creator>
		<dc:creator>Pierre Duez</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12520">
	<title><![CDATA[IJMS, Vol. 14, Pages 12520-12532: Activity of Laccase Immobilized on  TiO2-Montmorillonite Complexes]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12520</link>
	<description>The TiO2-montmorillonite (TiO2-MMT) complex was prepared by blending TiO2 sol and MMT with certain ratio, and its properties as an enzyme immobilization support were investigated. The pristine MMT and TiO2-MMT calcined at 800 °C  (TiO2-MMT800) were used for comparison to better understand the immobilization mechanism. The structures of the pristine MMT, TiO2-MMT, and TiO2-MMT800 were examined by HR-TEM, XRD and BET. SEM was employed to study different morphologies before and after laccase immobilization. Activity and kinetic parameters of the immobilized laccase were also determined. It was found that the TiO2 nanoparticles were successfully introduced into the MMT layer structure, and this intercalation enlarged the “d value” of two adjacent MMT layers and increased the surface area, while the calcination process led to a complete collapse of the MMT layers. SEM results showed that the clays were well coated with adsorbed enzymes. The study of laccase activity revealed that the optimum pH and temperature were pH = 3 and 60 °C, respectively. In addition, the storage stability for the immobilized laccase was satisfactory. The kinetic properties indicated that laccase immobilized on TiO2-MMT complexes had a good affinity to the substrate. It has been proved that TiO2-MMT complex is a good candidate for  enzyme immobilization.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-14</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612520</prism:doi>
	<prism:startingPage>12520</prism:startingPage>
		<prism:endingPage>12532</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Activity of Laccase Immobilized on  TiO2-Montmorillonite Complexes]]></dc:title>
    <dc:date>2013-06-14</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612520</dc:identifier>
    	<dc:creator>Qingqing Wang</dc:creator>
		<dc:creator>Lin Peng</dc:creator>
		<dc:creator>Guohui Li</dc:creator>
		<dc:creator>Ping Zhang</dc:creator>
		<dc:creator>Dawei Li</dc:creator>
		<dc:creator>Fenglin Huang</dc:creator>
		<dc:creator>Qufu Wei</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12496">
	<title><![CDATA[IJMS, Vol. 14, Pages 12496-12519: Targeting Alternative Sites on the Androgen Receptor to  Treat Castration-Resistant Prostate Cancer]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12496</link>
	<description>Recurrent, metastatic prostate cancer continues to be a leading cause of  cancer-death in men. The androgen receptor (AR) is a modular, ligand-inducible transcription factor that regulates the expression of genes that can drive the progression of this disease, and as a consequence, this receptor is a key therapeutic target for controlling prostate cancer. The current drugs designed to directly inhibit the AR are called  anti-androgens, and all act by competing with androgens for binding to the androgen/ligand binding site. Unfortunately, with the inevitable progression of the cancer to castration resistance, many of these drugs become ineffective. However, there are numerous other regulatory sites on this protein that have not been exploited therapeutically. The regulation of AR activity involves a cascade of complex interactions with numerous chaperones,  co-factors and co-regulatory proteins, leading ultimately to direct binding of AR dimers to specific DNA androgen response elements within the promoter and enhancers of  androgen-regulated genes. As part of the family of nuclear receptors, the AR is organized into modular structural and functional domains with specialized roles in facilitating their inter-molecular interactions. These regions of the AR present attractive, yet largely unexploited, drug target sites for reducing or eliminating androgen signaling in prostate cancers. The design of small molecule inhibitors targeting these specific AR domains is only now being realized and is the culmination of decades of work, including crystallographic and biochemistry approaches to map the shape and accessibility of the AR surfaces and cavities. Here, we review the structure of the AR protein and describe recent advancements in inhibiting its activity with small molecules specifically designed to target areas distinct from the receptor’s androgen binding site. It is anticipated that these new classes of anti-AR drugs will provide an additional arsenal to treat castration-resistant prostate cancer.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-14</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612496</prism:doi>
	<prism:startingPage>12496</prism:startingPage>
		<prism:endingPage>12519</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Targeting Alternative Sites on the Androgen Receptor to  Treat Castration-Resistant Prostate Cancer]]></dc:title>
    <dc:date>2013-06-14</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612496</dc:identifier>
    	<dc:creator>Nada Lallous</dc:creator>
		<dc:creator>Kush Dalal</dc:creator>
		<dc:creator>Artem Cherkasov</dc:creator>
		<dc:creator>Paul Rennie</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12484">
	<title><![CDATA[IJMS, Vol. 14, Pages 12484-12495: Facile Synthesis of 5-Arylidene Thiohydantoin by Sequential Sulfonylation/Desulfination Reaction]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12484</link>
	<description>The sequential sulfonylation/desulfination reactions of 5-benzylthiohydantoin with excess arylsulfonyl chlorides in the presence of triethylamine have been developed to afford a wide range of 5-arylidene thiohydantoin derivatives in moderate to excellent yields. A plausible sulfonylation/desulfination mechanism was proposed. The bioassay showed that these compounds exhibit certain fungicidal activities with the 71.9% inhibition rate of 2K against B. cinerea, and 57.6% inhibition rate of 2m against A. solani, respectively.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-13</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612484</prism:doi>
	<prism:startingPage>12484</prism:startingPage>
		<prism:endingPage>12495</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Facile Synthesis of 5-Arylidene Thiohydantoin by Sequential Sulfonylation/Desulfination Reaction]]></dc:title>
    <dc:date>2013-06-13</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612484</dc:identifier>
    	<dc:creator>Jintao Han</dc:creator>
		<dc:creator>Hongbo Dong</dc:creator>
		<dc:creator>Zhihong Xu</dc:creator>
		<dc:creator>Jianping Lei</dc:creator>
		<dc:creator>Mingan Wang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12458">
	<title><![CDATA[IJMS, Vol. 14, Pages 12458-12483: The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12458</link>
	<description>Melatonin exerts its actions through membrane MT1/MT2 melatonin receptors, which belong to the super family of G-protein-coupled receptors consisting of the typical seven transmembrane domains. MT1 and MT2 receptors are expressed in various tissues of the body either as single ones or together. A growing literature suggests that the melatonergic system may be involved in the pathophysiology of mood and anxiety disorders. In fact, some core symptoms of depression show disturbance of the circadian rhythm in their clinical expression, such as diurnal mood and other symptomatic variation, or are closely linked to circadian system functioning, such as sleep-wake cycle alterations. In addition, alterations have been described in the circadian rhythms of several biological markers in depressed patients. Therefore, there is interest in developing antidepressants that have a chronobiotic effect (i.e., treatment of circadian rhythm disorders). As melatonin produces chronobiotic effects, efforts have been aimed at developing agomelatine, an antidepressant with melatonin agonist activity. The present paper reviews the role of the melatonergic system in the pathophysiology of mood and anxiety disorders and the clinical characteristics of agomelatine. Implications of agomelatine in “real world” clinical practice will be also discussed.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-13</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612458</prism:doi>
	<prism:startingPage>12458</prism:startingPage>
		<prism:endingPage>12483</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice]]></dc:title>
    <dc:date>2013-06-13</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612458</dc:identifier>
    	<dc:creator>Domenico De Berardis</dc:creator>
		<dc:creator>Stefano Marini</dc:creator>
		<dc:creator>Michele Fornaro</dc:creator>
		<dc:creator>Venkataramanujam Srinivasan</dc:creator>
		<dc:creator>Felice Iasevoli</dc:creator>
		<dc:creator>Carmine Tomasetti</dc:creator>
		<dc:creator>Alessandro Valchera</dc:creator>
		<dc:creator>Giampaolo Perna</dc:creator>
		<dc:creator>Maria-Antonia Quera-Salva</dc:creator>
		<dc:creator>Giovanni Martinotti</dc:creator>
		<dc:creator>Massimo di Giannantonio</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12411">
	<title><![CDATA[IJMS, Vol. 14, Pages 12411-12457: Protein Folding and Aggregation into Amyloid:  The Interference by Natural Phenolic Compounds]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12411</link>
	<description>Amyloid aggregation is a hallmark of several degenerative diseases affecting the brain or peripheral tissues, whose intermediates (oligomers, protofibrils) and final mature fibrils display different toxicity. Consequently, compounds counteracting amyloid aggregation have been investigated for their ability (i) to stabilize toxic amyloid precursors; (ii) to prevent the growth of toxic oligomers or speed that of fibrils; (iii) to inhibit fibril growth and deposition; (iv) to disassemble preformed fibrils; and (v) to favor amyloid clearance. Natural phenols, a wide panel of plant molecules, are one of the most actively investigated categories of potential amyloid inhibitors. They are considered responsible for the beneficial effects of several traditional diets being present in green tea, extra virgin olive oil, red wine, spices, berries and aromatic herbs. Accordingly, it has been proposed that some natural phenols could be exploited to prevent and to treat amyloid diseases, and recent studies have provided significant information on their ability to inhibit peptide/protein aggregation in various ways and to stimulate cell defenses, leading to identify shared or specific mechanisms. In the first part of this review, we will overview the significance and mechanisms of amyloid aggregation and aggregate toxicity; then, we will summarize the recent achievements on protection against amyloid diseases by many natural phenols.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-13</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612411</prism:doi>
	<prism:startingPage>12411</prism:startingPage>
		<prism:endingPage>12457</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Protein Folding and Aggregation into Amyloid:  The Interference by Natural Phenolic Compounds]]></dc:title>
    <dc:date>2013-06-13</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612411</dc:identifier>
    	<dc:creator>Massimo Stefani</dc:creator>
		<dc:creator>Stefania Rigacci</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12401">
	<title><![CDATA[IJMS, Vol. 14, Pages 12401-12410: Immunomodulatory Activity of Recombinant Ricin Toxin Binding Subunit B (RTB)]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12401</link>
	<description>Ricin toxin binding subunit B (RTB) is one of the subunits of the ricin protein. RTB has been used as adjuvant, but little is known about its mechanism. In this study, we found that RTB increased not only nitric oxide (NO) release, but also tumor necrosis factor (TNF)-α and interleukin (IL)-6 production in mouse macrophage cell line RAW264.7 cells. They subsequently exhibited enhanced ConA-induced T-cell and LPS-induced B-cell proliferative responses. We also examined the cytokines that were produced from splenocytes following in vitro RTB administration. Increased levels of IL-2, interferon (IFN)-γ and TNF-α were observed, while IL-4 and IL-5 were unaffected. These results demonstrate that recombinant RTB can act on the immune system and activate T-cells by introducing a Th1 immune response. Th1 cells might be the primary cellular target affected by RTB. Our results suggest that the recombinant RTB can promote the activation of macrophages and has a beneficial effect on immunomodulatory activity.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-13</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612401</prism:doi>
	<prism:startingPage>12401</prism:startingPage>
		<prism:endingPage>12410</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Immunomodulatory Activity of Recombinant Ricin Toxin Binding Subunit B (RTB)]]></dc:title>
    <dc:date>2013-06-13</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612401</dc:identifier>
    	<dc:creator>Wensen Liu</dc:creator>
		<dc:creator>Na Xu</dc:creator>
		<dc:creator>Hongyan Yuan</dc:creator>
		<dc:creator>Songyan Li</dc:creator>
		<dc:creator>Linna Liu</dc:creator>
		<dc:creator>Zhaoyang Pu</dc:creator>
		<dc:creator>Jiayu Wan</dc:creator>
		<dc:creator>Huiwen Wang</dc:creator>
		<dc:creator>Yaping Chang</dc:creator>
		<dc:creator>Ruisheng Li</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12380">
	<title><![CDATA[IJMS, Vol. 14, Pages 12380-12400: Lymphocytes of Patients with Alzheimer’s Disease Display Different DNA Damage Repair Kinetics and Expression Profiles of DNA Repair and Stress Response Genes]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12380</link>
	<description>Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, characterized by loss of memory and cognitive capacity. Given the limitations to analyze brain cells, it is important to study whether peripheral lymphocytes can provide biological markers for AD, an interesting approach, once they represent the overall condition of the organism. To that extent, we sought to find whether lymphocytes of AD patients present DNA damage and repair kinetics different from those found in elderly matched controls (EC group) under in vitro treatment with hydrogen peroxide. We found that AD patient cells indeed showed an altered DNA repair kinetics (comet assay). Real-time quantitative analysis of genes associated with DNA stress response also showed that FANCG and CDKN1A are upregulated in AD, while MTH1 is downregulated, compared with the control group. In contrast, the expression of ATM, ATR and FEN1 genes does not seem to differ between these groups. Interestingly, TP53 protein expression was increased in AD patients. Therefore, we found that kinetics of the stress response in the DNA were significantly different in AD patients, supporting the hypothesis that repair pathways may be compromised in AD and that peripheral lymphocytes can reveal this condition.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-10</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612380</prism:doi>
	<prism:startingPage>12380</prism:startingPage>
		<prism:endingPage>12400</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Lymphocytes of Patients with Alzheimer’s Disease Display Different DNA Damage Repair Kinetics and Expression Profiles of DNA Repair and Stress Response Genes]]></dc:title>
    <dc:date>2013-06-10</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612380</dc:identifier>
    	<dc:creator>Giovana Leandro</dc:creator>
		<dc:creator>Romulo Lobo</dc:creator>
		<dc:creator>Douglas Oliveira</dc:creator>
		<dc:creator>Julio Moriguti</dc:creator>
		<dc:creator>Elza Sakamoto-Hojo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12367">
	<title><![CDATA[IJMS, Vol. 14, Pages 12367-12379: Expression and Role of GPR87 in Urothelial Carcinoma  of the Bladder]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12367</link>
	<description>The orphan GPR87 has recently been matched with its ligand LPA, which is a lipid mediator with multiple physiological functions, including cancer cell proliferation. This study aimed to clarify the role of GPR87 in urothelial carcinoma of the bladder. GPR87 expression was assessed in seven human bladder cancer cell lines. A replication-deficient recombinant adenoviral vector expressing shRNA targeting GPR87 (Ad-shGPR87), was constructed. Gene silencing was carried out using Ad-shGPR87. Immunohistochemical analysis was performed for transurethral resection of bladder tumor samples from 71 patients with non-muscle-invasive bladder cancer. We observed GPR87 expression in five of the seven cell lines, and silencing GPR87 gene expression significantly reduced cell viability. GPR87 expression was positive in 38 (54%) of 71 tumors. Ki-67 index was associated with positive GPR87 staining status (p &amp;amp;lt; 0.0001). Patients with GPR87-positive tumors had shorter intravesical recurrence-free survival than those with GPR87-negative tumors  (p = 0.010). Multivariate analysis revealed that GPR87 staining status was an independent prognostic parameter for intravesical recurrence (p = 0.041). Progression from  non-muscle-invasive to muscle-invasive tumor was more frequently observed in patients with GPR87-positive tumors, although this trend did not reach statistical significance  (p = 0.056). These results warrant further prospective studies to clarify the role of GPR87 expression in intravesical recurrence and progression in bladder cancer.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-10</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612367</prism:doi>
	<prism:startingPage>12367</prism:startingPage>
		<prism:endingPage>12379</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Expression and Role of GPR87 in Urothelial Carcinoma  of the Bladder]]></dc:title>
    <dc:date>2013-06-10</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612367</dc:identifier>
    	<dc:creator>Homare Okazoe</dc:creator>
		<dc:creator>Xia Zhang</dc:creator>
		<dc:creator>Dage Liu</dc:creator>
		<dc:creator>Shinsuke Shibuya</dc:creator>
		<dc:creator>Nobufumi Ueda</dc:creator>
		<dc:creator>Mikio Sugimoto</dc:creator>
		<dc:creator>Yoshiyuki Kakehi</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12346">
	<title><![CDATA[IJMS, Vol. 14, Pages 12346-12366: Urinary Bladder Cancer Susceptibility Markers.  What Do We Know about Functional Mechanisms?]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12346</link>
	<description>Genome-wide association studies (GWAS) have been successful in the identification of the several urinary bladder cancer (UBC) susceptibility loci, pointing towards novel genes involved in tumor development. Despite that, functional characterization of the identified variants remains challenging, as they mostly map to poorly understood, non-coding regions. Recently, two of the UBC risk variants (PSCA and UGT1A) were confirmed to have functional consequences. They were shown to modify bladder cancer risk by influencing gene expression in an allele-specific manner. Although the role of the other UBC risk variants is unknown, it can be hypothesized—based on studies from different cancer types—that they influence cancer susceptibility by alterations in regulatory networks. The insight into UBC heritability gained through GWAS and further functional studies can impact on cancer prevention and screening, as well as on the development of new biomarkers and future personalized therapies.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-10</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612346</prism:doi>
	<prism:startingPage>12346</prism:startingPage>
		<prism:endingPage>12366</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Urinary Bladder Cancer Susceptibility Markers.  What Do We Know about Functional Mechanisms?]]></dc:title>
    <dc:date>2013-06-10</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612346</dc:identifier>
    	<dc:creator>Aleksandra Dudek</dc:creator>
		<dc:creator>Anne Grotenhuis</dc:creator>
		<dc:creator>Sita Vermeulen</dc:creator>
		<dc:creator>Lambertus Kiemeney</dc:creator>
		<dc:creator>Gerald Verhaegh</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12329">
	<title><![CDATA[IJMS, Vol. 14, Pages 12329-12345: An Investigation of the Effects of Self-Assembled Monolayers on Protein Crystallisation]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12329</link>
	<description>Most protein crystallisation begins from heterogeneous nucleation; in practice, crystallisation typically occurs in the presence of a solid surface in the solution. The solid surface provides a nucleation site such that the energy barrier for nucleation is lower on the surface than in the bulk solution. Different types of solid surfaces exhibit different surface energies, and the nucleation barriers depend on the characteristics of the solid surfaces. Therefore, treatment of the solid surface may alter the surface properties to increase the chance to obtain protein crystals. In this paper, we propose a method to modify the glass cover slip using a self-assembled monolayer (SAM) of functional groups (methyl, sulfydryl and amino), and we investigated the effect of each SAM on protein crystallisation. The results indicated that both crystallisation success rate in a reproducibility study, and crystallisation hits in a crystallisation screening study, were increased using the SAMs, among which, the methyl-modified SAM demonstrated the most significant improvement. These results illustrated that directly modifying the crystallisation plates or glass cover slips to create surfaces that favour heterogeneous nucleation can be potentially useful in practical protein crystallisation, and the utilisation of a SAM containing a functional group can be considered a promising technique for the treatment of the surfaces that will directly contact the crystallisation solution.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-07</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612329</prism:doi>
	<prism:startingPage>12329</prism:startingPage>
		<prism:endingPage>12345</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[An Investigation of the Effects of Self-Assembled Monolayers on Protein Crystallisation]]></dc:title>
    <dc:date>2013-06-07</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612329</dc:identifier>
    	<dc:creator>Chen-Yan Zhang</dc:creator>
		<dc:creator>He-Fang Shen</dc:creator>
		<dc:creator>Qian-Jin Wang</dc:creator>
		<dc:creator>Yun-Zhu Guo</dc:creator>
		<dc:creator>Jin He</dc:creator>
		<dc:creator>Hui-Ling Cao</dc:creator>
		<dc:creator>Yong-Ming Liu</dc:creator>
		<dc:creator>Peng Shang</dc:creator>
		<dc:creator>Da-Chuan Yin</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12313">
	<title><![CDATA[IJMS, Vol. 14, Pages 12313-12328: Contribution of the Tyr-1 in Plantaricin149a to Disrupt Phospholipid Model Membranes]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12313</link>
	<description>Plantaricin149a (Pln149a) is a cationic antimicrobial peptide, which was suggested to cause membrane destabilization via the carpet mechanism. The mode of action proposed to this antimicrobial peptide describes the induction of an amphipathic α-helix from Ala7 to Lys20, while the N-terminus residues remain in a coil conformation after binding. To better investigate this assumption, the purpose of this study was to determine the contributions of the Tyr1 in Pln149a in the binding to model membranes to promote its destabilization. The Tyr to Ser substitution increased the dissociation constant (KD) of the antimicrobial peptide from the liposomes (approximately three-fold higher), and decreased the enthalpy of binding to anionic vesicles from −17.2 kcal/mol to −10.2 kcal/mol. The peptide adsorption/incorporation into the negatively charged lipid vesicles was less effective with the Tyr1 substitution and peptide Pln149a perturbed the liposome integrity more than the analog, Pln149S. Taken together, the peptide-lipid interactions that govern the Pln149a antimicrobial activity are found not only in the amphipathic helix, but also in the N-terminus residues, which take part in enthalpic contributions due to the allocation at a lipid-aqueous interface.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-07</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612313</prism:doi>
	<prism:startingPage>12313</prism:startingPage>
		<prism:endingPage>12328</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Contribution of the Tyr-1 in Plantaricin149a to Disrupt Phospholipid Model Membranes]]></dc:title>
    <dc:date>2013-06-07</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612313</dc:identifier>
    	<dc:creator>José Lopes</dc:creator>
		<dc:creator>Maria Gómara</dc:creator>
		<dc:creator>Isabel Haro</dc:creator>
		<dc:creator>Georgina Tonarelli</dc:creator>
		<dc:creator>Leila Beltramini</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12297">
	<title><![CDATA[IJMS, Vol. 14, Pages 12297-12312: Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and  Survivin in Combination with Chemotherapy]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12297</link>
	<description>The overexpression of antiapoptotic genes, such as Bcl-xL and survivin, contributes to the increased survival of tumor cells and to the development of treatment resistances. In the bladder cancer cell lines EJ28 and J82, the siRNA-mediated knockdown of survivin reduces cell proliferation and the inhibition of Bcl-xL sensitizes these cells towards subsequent chemotherapy with mitomycin C and cisplatin. Therefore, the aim of this study was to analyze if the simultaneous knockdown of Bcl-xL and survivin might represent a more powerful treatment option for bladder cancer than the single inhibition of one of these target genes. At 96 h after transfection, reduction in cell viability was stronger after simultaneous inhibition of Bcl-xL and survivin (decrease of 40%–48%) in comparison to the single target treatments (decrease of 29% at best). Furthermore, simultaneous knockdown of Bcl-xL and survivin considerably increased the efficacy of subsequent chemotherapy. For example, cellular viability of EJ28 cells decreased to 6% in consequence of Bcl-xL and survivin inhibition plus cisplatin treatment whereas single target siRNA plus chemotherapy treatments mediated reductions down to 15%–36% only. In conclusion, the combination of simultaneous siRNA-mediated knockdown of antiapoptotic Bcl-xL and survivin—a multitarget molecular-based therapy—and conventional chemotherapy shows great potential for improving bladder cancer treatment.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-07</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612297</prism:doi>
	<prism:startingPage>12297</prism:startingPage>
		<prism:endingPage>12312</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and  Survivin in Combination with Chemotherapy]]></dc:title>
    <dc:date>2013-06-07</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612297</dc:identifier>
    	<dc:creator>Doreen Kunze</dc:creator>
		<dc:creator>Kati Erdmann</dc:creator>
		<dc:creator>Michael Froehner</dc:creator>
		<dc:creator>Manfred Wirth</dc:creator>
		<dc:creator>Susanne Fuessel</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12273">
	<title><![CDATA[IJMS, Vol. 14, Pages 12273-12296: Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster; Evidence for Involvement of Pim-1]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12273</link>
	<description>The human polycistronic miRNA cluster miR-17-92 is frequently overexpressed in hematopoietic malignancies and cancers. Its transcription is in part controlled by an E2F-regulated host gene promoter. An intronic A/T-rich region directly upstream of the miRNA coding region also contributes to cluster expression. Our deletion analysis of the A/T-rich region revealed a strong dependence on c-Myc binding to the functional E3 site. Yet, constructs lacking the 5&#039;-proximal ~1.3 kb or 3&#039;-distal ~0.1 kb of the 1.5 kb A/T-rich region still retained residual specific promoter activity, suggesting multiple transcription start sites (TSS) in this region. Furthermore, the protooncogenic kinase, Pim-1, its phosphorylation target HP1γ and c-Myc colocalize to the E3 region, as inferred from chromatin immunoprecipitation. Analysis of pri-miR-17-92 expression levels in K562 and HeLa cells revealed that silencing of E2F3, c-Myc or Pim-1 negatively affects cluster expression, with a synergistic effect caused by c-Myc/Pim-1 double knockdown in HeLa cells. Thus, we show, for the first time, that the protooncogene Pim-1 is part of the network that regulates transcription of the human miR-17-92 cluster.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-07</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612273</prism:doi>
	<prism:startingPage>12273</prism:startingPage>
		<prism:endingPage>12296</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster; Evidence for Involvement of Pim-1]]></dc:title>
    <dc:date>2013-06-07</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612273</dc:identifier>
    	<dc:creator>Maren Thomas</dc:creator>
		<dc:creator>Kerstin Lange-Grünweller</dc:creator>
		<dc:creator>Dorothee Hartmann</dc:creator>
		<dc:creator>Lara Golde</dc:creator>
		<dc:creator>Julia Schlereth</dc:creator>
		<dc:creator>Dennis Streng</dc:creator>
		<dc:creator>Achim Aigner</dc:creator>
		<dc:creator>Arnold Grünweller</dc:creator>
		<dc:creator>Roland Hartmann</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12249">
	<title><![CDATA[IJMS, Vol. 14, Pages 12249-12272: Thrombospondin-1 in Urological Cancer: Pathological Role, Clinical Significance, and Therapeutic Prospects]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12249</link>
	<description>Angiogenesis is an important process for tumor growth and progression of various solid tumors including urological cancers. Thrombospondins (TSPs), especially TSP-1, are representative “anti”-angiogenic molecules and many studies have clarified their pathological role and clinical significance in vivo and in vitro. In fact, TSP-1 expression is associated with clinicopathological features and prognosis in many types of cancers. However, TSP-1 is a multi-functional protein and its biological activities vary according  to the specific tumor environments. Consequently, there is no general agreement on its cancer-related function in urological cancers, and detailed information regarding regulative mechanisms is essential for a better understanding of its therapeutic effects and prognostic values. Various “suppressor genes” and “oncogenes” are known to be regulators and TSP-1-related factors under physiological and pathological conditions. In addition, various types of fragments derived from TSP-1 exist in a given tissue microenvironment and TSP-1 derived-peptides have specific activities. However, a detailed pathological function in human cancer tissues is not still understood. This review will focus on the pathological roles and clinical significance of TSP-1 in urological cancers, including prostate cancer, renal cell carcinoma, and urothelial cancer. In addition, special attention is paid to TSP-1-derived peptide and TSP-1-based therapy for malignancies.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-07</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612249</prism:doi>
	<prism:startingPage>12249</prism:startingPage>
		<prism:endingPage>12272</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Thrombospondin-1 in Urological Cancer: Pathological Role, Clinical Significance, and Therapeutic Prospects]]></dc:title>
    <dc:date>2013-06-07</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612249</dc:identifier>
    	<dc:creator>Yasuyoshi Miyata</dc:creator>
		<dc:creator>Hideki Sakai</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12222">
	<title><![CDATA[IJMS, Vol. 14, Pages 12222-12248: UV Radiation and the Skin]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12222</link>
	<description>UV radiation (UV) is classified as a “complete carcinogen” because it is both a mutagen and a non-specific damaging agent and has properties of both a tumor initiator and a tumor promoter. In environmental abundance, UV is the most important modifiable risk factor for skin cancer and many other environmentally-influenced skin disorders. However, UV also benefits human health by mediating natural synthesis of vitamin D and endorphins in the skin, therefore UV has complex and mixed effects on human health. Nonetheless, excessive exposure to UV carries profound health risks, including atrophy, pigmentary changes, wrinkling and malignancy. UV is epidemiologically and molecularly linked to the three most common types of skin cancer, basal cell carcinoma, squamous cell carcinoma and malignant melanoma, which together affect more than a million Americans annually. Genetic factors also influence risk of UV-mediated skin disease. Polymorphisms of the melanocortin 1 receptor (MC1R) gene, in particular, correlate with fairness of skin, UV sensitivity, and enhanced cancer risk. We are interested in developing UV-protective approaches based on a detailed understanding of molecular events that occur after UV exposure, focusing particularly on epidermal melanization and the role of the MC1R in genome maintenance.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-07</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612222</prism:doi>
	<prism:startingPage>12222</prism:startingPage>
		<prism:endingPage>12248</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[UV Radiation and the Skin]]></dc:title>
    <dc:date>2013-06-07</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612222</dc:identifier>
    	<dc:creator>John D&#039;Orazio</dc:creator>
		<dc:creator>Stuart Jarrett</dc:creator>
		<dc:creator>Alexandra Amaro-Ortiz</dc:creator>
		<dc:creator>Timothy Scott</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12205">
	<title><![CDATA[IJMS, Vol. 14, Pages 12205-12221: Enhancement of Immune Activation Activities of  Spirulina maxima Grown in Deep-Sea Water]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12205</link>
	<description>In this study, the immuno-modulatory and anticancer activities of marine algae, Spirulina maxima grown in deep-sea water (DSW), were investigated. It was found that the extract of S. maxima, cultured in DSW, effectively suppressed the expression of Bcl2 in A549 cells as well as inhibiting various human cancer cells with concentration dependency, which possibly implies that the extracts may play more important roles in controlling cancer cell growth. The secretion of cytokines IL-6 and TNF-α from human B cells was also greatly increased, compared to those of the extract grown in conventional sea-water. The growth of Human Natural Killer (NK) cells in the presence of the extracts from DSW was significantly higher (12.2 × 104 viable cells/mL) when compared to the control (1.1 × 104 viable cells/mL). Based on HPLC analysis, the increase in the biological activities of the extracts from DSW was caused by considerably high amounts of  β-carotene and ascorbic acid because the DSW contained high concentrations and good ratios of several key minerals for biosynthesizing β-carotene and ascorbic acid, as well as maintaining high cell growth.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612205</prism:doi>
	<prism:startingPage>12205</prism:startingPage>
		<prism:endingPage>12221</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Enhancement of Immune Activation Activities of  Spirulina maxima Grown in Deep-Sea Water]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612205</dc:identifier>
    	<dc:creator>Woon Choi</dc:creator>
		<dc:creator>Do Kang</dc:creator>
		<dc:creator>Hyeon Lee</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12186">
	<title><![CDATA[IJMS, Vol. 14, Pages 12186-12204: Effect of GABA, a Bacterial Metabolite,  on Pseudomonas fluorescens Surface Properties and Cytotoxicity]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12186</link>
	<description>Different bacterial species and, particularly Pseudomonas fluorescens, can produce gamma-aminobutyric acid (GABA) and express GABA-binding proteins. In this study, we investigated the effect of GABA on the virulence and biofilm formation activity of different strains of P. fluorescens. Exposure of a psychotropic strain of P. fluorescens (MF37) to GABA (10−5 M) increased its necrotic-like activity on eukaryotic (glial) cells, but reduced its apoptotic effect. Conversely, muscimol and bicuculline, the selective agonist and antagonist of eukaryote GABAA receptors, respectively, were ineffective.  P. fluorescens MF37 did not produce biosurfactants, and its caseinase, esterase, amylase, hemolytic activity or pyoverdine productions were unchanged. In contrast, the effect of GABA was associated to rearrangements of the lipopolysaccharide (LPS) structure, particularly in the lipid A region. The surface hydrophobicity of MF37 was marginally modified, and GABA reduced its biofilm formation activity on PVC, but not on glass, although the initial adhesion was increased. Five other P. fluorescens strains were studied, and only one, MFP05, a strain isolated from human skin, showed structural differences of biofilm maturation after exposure to GABA. These results reveal that GABA can regulate the LPS structure and cytotoxicity of P. fluorescens, but that this property is specific to some strains.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612186</prism:doi>
	<prism:startingPage>12186</prism:startingPage>
		<prism:endingPage>12204</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Effect of GABA, a Bacterial Metabolite,  on Pseudomonas fluorescens Surface Properties and Cytotoxicity]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612186</dc:identifier>
    	<dc:creator>Audrey Dagorn</dc:creator>
		<dc:creator>Annelise Chapalain</dc:creator>
		<dc:creator>Lily Mijouin</dc:creator>
		<dc:creator>Mélanie Hillion</dc:creator>
		<dc:creator>Cécile Duclairoir-Poc</dc:creator>
		<dc:creator>Sylvie Chevalier</dc:creator>
		<dc:creator>Laure Taupin</dc:creator>
		<dc:creator>Nicole Orange</dc:creator>
		<dc:creator>Marc Feuilloley</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12170">
	<title><![CDATA[IJMS, Vol. 14, Pages 12170-12185: Serum Metallothioneins in Childhood Tumours—A Potential Prognostic Marker]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12170</link>
	<description>Metallothioneins (MT) are low molecular weight, cysteine-rich proteins maintaining metal ions homeostasis. They play a role in carcinogenesis and may also cause chemoresistance. The aim of the study was to explore the importance of MT serum levels in children suffering from malignant tumours. This prospective study involves examination of 865 samples from 172 patients with malignant tumours treated from 2008 to 2011 at University Hospital Motol. MT serum levels were determined using differential pulse voltammetry–Brdicka reaction. Mean MT level was 2.7 ± 0.5 μM. There was no statistically significant difference between MT levels in different tumours. We also did not find any correlation between MT levels and response to therapy or clinical stages. However, we found a positive correlation between MT levels and age (p = 0.009) and a negative correlation with absolute lymphocyte number (p = 0.001). The fact that patients who had early disease recurrence had lower MT levels during the treatment (complete remission 2.67 vs. recurring 2.34, p = 0.001) seems to be important for clinical practice. Accordingly we believe that there is benefit in further studies of serum MT levels  in tumours.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612170</prism:doi>
	<prism:startingPage>12170</prism:startingPage>
		<prism:endingPage>12185</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Serum Metallothioneins in Childhood Tumours—A Potential Prognostic Marker]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612170</dc:identifier>
    	<dc:creator>Jarmila Kruseova</dc:creator>
		<dc:creator>David Hynek</dc:creator>
		<dc:creator>Vojtech Adam</dc:creator>
		<dc:creator>Rene Kizek</dc:creator>
		<dc:creator>Richard Prusa</dc:creator>
		<dc:creator>Jan Hrabeta</dc:creator>
		<dc:creator>Tomas Eckschlager</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12157">
	<title><![CDATA[IJMS, Vol. 14, Pages 12157-12169: A Hamiltonian Replica Exchange Molecular Dynamics (MD) Method for the Study of Folding, Based on the Analysis of the Stabilization Determinants of Proteins]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12157</link>
	<description>Herein, we present a novel Hamiltonian replica exchange protocol for classical molecular dynamics simulations of protein folding/unfolding. The scheme starts from the analysis of the energy-networks responsible for the stabilization of the folded conformation, by means of the energy-decomposition approach. In this framework, the compact energetic map of the native state is generated by a preliminary short molecular dynamics (MD) simulation of the protein in explicit solvent. This map is simplified by means of an eigenvalue decomposition. The highest components of the eigenvector associated with the lowest eigenvalue indicate which sites, named “hot spots”, are likely to be responsible for the stability and correct folding of the protein. In the Hamiltonian replica exchange protocol, we use modified force-field parameters to treat the interparticle  non-bonded potentials of the hot spots within the protein and between protein and solvent atoms, leaving unperturbed those relative to all other residues, as well as solvent-solvent interactions. We show that it is possible to reversibly simulate the folding/unfolding behavior of two test proteins, namely Villin HeadPiece HP35 (35 residues) and Protein A (62 residues), using a limited number of replicas. We next discuss possible implications for the study of folding mechanisms via all atom simulations.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612157</prism:doi>
	<prism:startingPage>12157</prism:startingPage>
		<prism:endingPage>12169</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[A Hamiltonian Replica Exchange Molecular Dynamics (MD) Method for the Study of Folding, Based on the Analysis of the Stabilization Determinants of Proteins]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612157</dc:identifier>
    	<dc:creator>Massimiliano Meli</dc:creator>
		<dc:creator>Giorgio Colombo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12138">
	<title><![CDATA[IJMS, Vol. 14, Pages 12138-12156: Combining Hexanoic Acid Plant Priming with  Bacillus thuringiensis Insecticidal Activity against  Colorado Potato Beetle]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12138</link>
	<description>Interaction between insect herbivores and host plants can be modulated by endogenous and exogenous compounds present in the source of food and might be successfully exploited in Colorado potato beetle (CPB) pest management. Feeding tests with CPB larvae reared on three solanaceous plants (potato, eggplant and tomato) resulted in variable larval growth rates and differential susceptibility to Bacillus thuringiensis Cry3Aa toxin as a function of the host plant. An inverse correlation with toxicity was observed in Cry3Aa proteolytic patterns generated by CPB midgut brush-border membrane vesicles (BBMV) from Solanaceae-fed larvae, being the toxin most extensively proteolyzed on potato, followed by eggplant and tomato. We found that CPB cysteine proteases intestains may interact with Cry3Aa toxin and, in CPB BBMV from larvae fed all three Solanaceae, the toxin was able to compete for the hydrolysis of a papain substrate. In response to treatment with the JA-dependent plant inducer Hexanoic acid (Hx), we showed that eggplant reduced OPDA basal levels and both, potato and eggplant induced JA-Ile. CPB larvae feeding on Hx-induced plants exhibited enhanced Cry3Aa toxicity, which correlated with altered papain activity. Results indicated host-mediated effects on  B. thuringiensis efficacy against CPB that can be enhanced in combination with Hx  plant induction.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612138</prism:doi>
	<prism:startingPage>12138</prism:startingPage>
		<prism:endingPage>12156</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Combining Hexanoic Acid Plant Priming with  Bacillus thuringiensis Insecticidal Activity against  Colorado Potato Beetle]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612138</dc:identifier>
    	<dc:creator>Inmaculada García-Robles</dc:creator>
		<dc:creator>Camila Ochoa-Campuzano</dc:creator>
		<dc:creator>Emma Fernández-Crespo</dc:creator>
		<dc:creator>Gemma Camañes</dc:creator>
		<dc:creator>Amparo Martínez-Ramírez</dc:creator>
		<dc:creator>Carmen González-Bosch</dc:creator>
		<dc:creator>Pilar García-Agustín</dc:creator>
		<dc:creator>Carolina Rausell</dc:creator>
		<dc:creator>María Real</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12123">
	<title><![CDATA[IJMS, Vol. 14, Pages 12123-12137: Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12123</link>
	<description>The recent increase in the frequency of endometrial cancer has emphasized the need for accurate diagnosis and improved treatment. The current diagnosis is still based on conventional pathological indicators, such as clinical stage, tumor differentiation, invasion depth and vascular invasion. However, the genetic mechanisms underlying endometrial cancer have gradually been determined, due to developments in molecular biology, leading to the possibility of new methods of diagnosis and treatment planning. New candidate biomarkers for endometrial cancer include those for molecular epigenetic mutations, such as microRNAs. These biomarkers may permit earlier detection of endometrial cancer and prediction of outcomes and are likely to contribute to future personalized therapy for endometrial cancer.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612123</prism:doi>
	<prism:startingPage>12123</prism:startingPage>
		<prism:endingPage>12137</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612123</dc:identifier>
    	<dc:creator>Kouji Banno</dc:creator>
		<dc:creator>Yuya Nogami</dc:creator>
		<dc:creator>Iori Kisu</dc:creator>
		<dc:creator>Megumi Yanokura</dc:creator>
		<dc:creator>Kiyoko Umene</dc:creator>
		<dc:creator>Kenta Masuda</dc:creator>
		<dc:creator>Yusuke Kobayashi</dc:creator>
		<dc:creator>Wataru Yamagami</dc:creator>
		<dc:creator>Nobuyuki Susumu</dc:creator>
		<dc:creator>Daisuke Aoki</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12107">
	<title><![CDATA[IJMS, Vol. 14, Pages 12107-12122: Eviprostat Activates cAMP Signaling Pathway and Suppresses Bladder Smooth Muscle Cell Proliferation]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12107</link>
	<description>Eviprostat is a popular phytotherapeutic agent for the treatment of lower urinary tract symptoms (LUTS). At present, the signaling mechanisms underlying its therapeutic effects are still poorly understood. Given that cAMP has been reported to suppress cell hyperplasia and hypertrophy in various pathological situations, we asked whether the effect of Eviprostat could be ascribed to the activation of the cAMP signaling pathway. In the study, exposure of cAMP response element (CRE)-secreted alkaline phosphatase (SEAP) (CRE-SEAP)-reporter cells to Eviprostat elevated SEAP secretion, which was associated with an increased phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and cAMP-response element-binding protein (CREB), as well as enhanced expression of  CRE-regulated protein connexin43, indicating an activation of the cAMP signaling pathway. Consistent with these observations, Eviprostat-induced expression of Cx43 was abolished in the presence of adenylyl cyclase inhibitor SQ22536 or PKA inhibitor H89, whereas it was mimicked by adenylyl cyclase activator, forskolin. Further analysis demonstrated that Eviprostat significantly potentiated the effect of phosphodiesterase 3 (PDE3) inhibitor, but not that of PDE4 inhibitor, on CRE activation. Moreover, Eviprostat suppressed PDGF-induced activation of ERK and Akt and inhibited cell proliferation and hillock formation in both mesangial cells and bladder smooth muscle cells. Collectively, activation of the cAMP signaling pathway could be an important mechanism by which Eviprostat exerts its therapeutic effects for LUTS.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612107</prism:doi>
	<prism:startingPage>12107</prism:startingPage>
		<prism:endingPage>12122</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Eviprostat Activates cAMP Signaling Pathway and Suppresses Bladder Smooth Muscle Cell Proliferation]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612107</dc:identifier>
    	<dc:creator>Kai Li</dc:creator>
		<dc:creator>Jian Yao</dc:creator>
		<dc:creator>Yuan Chi</dc:creator>
		<dc:creator>Norifumi Sawada</dc:creator>
		<dc:creator>Isao Araki</dc:creator>
		<dc:creator>Masanori Kitamura</dc:creator>
		<dc:creator>Masayuki Takeda</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12090">
	<title><![CDATA[IJMS, Vol. 14, Pages 12090-12106: Autophagy in Prostate Cancer and Androgen  Suppression Therapy]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12090</link>
	<description>The role of autophagy is known to be highly complex and context-dependent, leading to both cancer suppression and progression in several tumors including melanoma, breast and prostate cancer. In the present review, recent advances in an understanding of the involvement of autophagy in prostate cancer treatment are described. The regulatory effects of androgens on prostate cancer cell autophagy are particularly discussed in order to highlight the effects of autophagy modulation during androgen deprivation. A critical evaluation of the studies examined in the present review suggests the attractive possibility of autophagy inhibition combined with hormonal therapy as a promising approach for prostate cancer treatment.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140612090</prism:doi>
	<prism:startingPage>12090</prism:startingPage>
		<prism:endingPage>12106</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Autophagy in Prostate Cancer and Androgen  Suppression Therapy]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612090</dc:identifier>
    	<dc:creator>Elio Ziparo</dc:creator>
		<dc:creator>Simonetta Petrungaro</dc:creator>
		<dc:creator>Elettra Marini</dc:creator>
		<dc:creator>Donatella Starace</dc:creator>
		<dc:creator>Silvia Conti</dc:creator>
		<dc:creator>Antonio Facchiano</dc:creator>
		<dc:creator>Antonio Filippini</dc:creator>
		<dc:creator>Claudia Giampietri</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12073">
	<title><![CDATA[IJMS, Vol. 14, Pages 12073-12089: Preparation of Novel Poly(hydroxyethyl methacrylate-co-glycidyl methacrylate)-Grafted Core-Shell Magnetic Chitosan Microspheres and Immobilization of Lactase]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12073</link>
	<description>Poly(hydroxyethyl methacrylate-co-glycidyl methacrylate)-grafted magnetic chitosan microspheres (HG-MCM) were prepared using reversed-phase suspension polymerization method. The HG-MCM presented a core-shell structure and regular spherical shape with poly(hydroxyethyl methacrylate-co-glycidyl methacrylate) grafted onto the chitosan layer coating the Fe3O4 cores. The average diameter of the magnetic microspheres was 10.67 μm, within a narrow size distribution of 6.6–17.4 μm. The saturation magnetization and retentivity of the magnetic microspheres were 7.0033 emu/g and 0.6273 emu/g, respectively. The application of HG-MCM in immobilization of lactase showed that the immobilized enzyme presented higher storage, pH and thermal stability compared to the free enzyme. This indicates that HG-MCM have potential applications in  bio-macromolecule immobilization.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-06</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612073</prism:doi>
	<prism:startingPage>12073</prism:startingPage>
		<prism:endingPage>12089</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Preparation of Novel Poly(hydroxyethyl methacrylate-co-glycidyl methacrylate)-Grafted Core-Shell Magnetic Chitosan Microspheres and Immobilization of Lactase]]></dc:title>
    <dc:date>2013-06-06</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612073</dc:identifier>
    	<dc:creator>Wei Zhao</dc:creator>
		<dc:creator>Rui-Jin Yang</dc:creator>
		<dc:creator>Ting-Ting Qian</dc:creator>
		<dc:creator>Xiao Hua</dc:creator>
		<dc:creator>Wen-Bin Zhang</dc:creator>
		<dc:creator>Wendy Katiyo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12054">
	<title><![CDATA[IJMS, Vol. 14, Pages 12054-12072: (+)-Dehydroabietic Acid, an Abietane-Type Diterpene,  Inhibits Staphylococcus aureus Biofilms in Vitro]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12054</link>
	<description>Potent drugs are desperately needed to counteract bacterial biofilm infections, especially those caused by gram-positive organisms, such as Staphylococcus aureus. Moreover, anti-biofilm compounds/agents that can be used as chemical tools are also needed for basic in vitro or in vivo studies aimed at exploring biofilms behavior and functionability. In this contribution, a collection of naturally-occurring abietane-type diterpenes and their derivatives was tested against S. aureus biofilms using a platform consisting of two phenotypic assays that have been previously published by our group. Three active compounds were identified: nordehydroabietylamine (1), (+)-dehydroabietic acid (2) and (+)-dehydroabietylamine (3) that prevented biofilm formation in the low micromolar range, and unlike typical antibiotics, only 2 to 4-fold higher concentrations were needed to significantly reduce viability and biomass of existing biofilms. Compound 2, (+)-dehydroabietic acid, was the most selective towards biofilm bacteria, achieving high killing efficacy (based on log Reduction values) and it was best tolerated by three different mammalian cell lines. Since (+)-dehydroabietic acid is an easily available compound, it holds great potential to be used as a molecular probe in biofilms-related studies as well as to serve as inspirational chemical model for the development of potent drug candidates.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-05</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612054</prism:doi>
	<prism:startingPage>12054</prism:startingPage>
		<prism:endingPage>12072</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[(+)-Dehydroabietic Acid, an Abietane-Type Diterpene,  Inhibits Staphylococcus aureus Biofilms in Vitro]]></dc:title>
    <dc:date>2013-06-05</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612054</dc:identifier>
    	<dc:creator>Adyary Fallarero</dc:creator>
		<dc:creator>Malena Skogman</dc:creator>
		<dc:creator>Janni Kujala</dc:creator>
		<dc:creator>Mohanathas Rajaratnam</dc:creator>
		<dc:creator>Vânia Moreira</dc:creator>
		<dc:creator>Jari Yli-Kauhaluoma</dc:creator>
		<dc:creator>Pia Vuorela</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12037">
	<title><![CDATA[IJMS, Vol. 14, Pages 12037-12053: Three Dimensional Quantitative Structure-Activity Relationship of 5H-Pyrido[4,3-b]indol-4-carboxamide JAK2 Inhibitors]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12037</link>
	<description>Janus kinase 2 (JAK2) is an intracellular nonreceptor tyrosine kinase that belongs to the JAK family of kinases, which play an important role in survival, proliferation, and differentiation of a variety of cells. JAK2 inhibitors are potential drugs for the treatment of myeloproliferative neoplasms. The three dimensional quantitative structure-activity relationships have been studied on a series of JAK2 inhibitors by comparative molecular field analysis (CoMFA), and comparative molecular similarity indices analysis (CoMSIA). The CoMFA model had a cross-validated coefficient q2 of 0.633, and the relation non-cross-validated coefficient r2 of 0.976. The F value is 225.030. The contributions of steric and electrostatic fields to the activity are 55.2% and 44.8%, respectively. For the CoMSIA study, the q2, r2, and F values of the model are 0.614, 0.929, and 88.771, respectively. The contributions of steric, electrostatic, hydrophobic, hydrogen bond donor, and hydrogen bond donor fields to the activity are 27.3%, 23.9%, 16.4%, 21.7%, and 10.7%, respectively. The CoMFA and CoMSIA models showed strong predictive ability, and the 3D contour plots give the basis on the structure modification of JAK2 inhibitors.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-05</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612037</prism:doi>
	<prism:startingPage>12037</prism:startingPage>
		<prism:endingPage>12053</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Three Dimensional Quantitative Structure-Activity Relationship of 5H-Pyrido[4,3-b]indol-4-carboxamide JAK2 Inhibitors]]></dc:title>
    <dc:date>2013-06-05</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612037</dc:identifier>
    	<dc:creator>Xiaoyun Wu</dc:creator>
		<dc:creator>Shanhe Wan</dc:creator>
		<dc:creator>Jiajie Zhang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12023">
	<title><![CDATA[IJMS, Vol. 14, Pages 12023-12036: Combination of Low Concentration of (−)-Epigallocatechin Gallate (EGCG) and Curcumin Strongly Suppresses the Growth of Non-Small Cell Lung Cancer in Vitro and in Vivo through Causing Cell Cycle Arrest]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12023</link>
	<description>(−)-Epigallocatechin gallate (EGCG) and curcumin are two naturally derived agents that have been widely investigated worldwide. They exhibit their anti-tumor effects in many types of cancers. In the current study, the effect of the combination of the two agents on non-small cell lung cancer (NSCLC) cells was investigated. The results revealed that at low concentrations, the combination of the EGCG and curcumin strongly enhanced cell cycle arrest. Flow cytometry analysis showed that the cells were arrested at G1 and S/G2 phases. Two main cell cycle related proteins cyclin D1 and cyclin B1 were significantly inhibited at the present of EGCG and curcumin. EdU (5-ethynyl-2&#039;-deoxyuridine) fluorescence staining showed that the DNA replication was significantly blocked. A clonal growth assay also confirmed a marked repression of cell growth. In a lung cancer xenograft node mice model, combination of EGCG and curcumin exhibited protective effect against weight loss due to tumor burden. Tumor growth was strongly repressed by the combination of the two agents, without causing any serious side-effect. Overall, these results strongly suggest that EGCG in combination with curcumin could be a candidate for chemoprevention agent of NSCLC.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-05</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612023</prism:doi>
	<prism:startingPage>12023</prism:startingPage>
		<prism:endingPage>12036</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Combination of Low Concentration of (−)-Epigallocatechin Gallate (EGCG) and Curcumin Strongly Suppresses the Growth of Non-Small Cell Lung Cancer in Vitro and in Vivo through Causing Cell Cycle Arrest]]></dc:title>
    <dc:date>2013-06-05</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612023</dc:identifier>
    	<dc:creator>Dong-Hu Zhou</dc:creator>
		<dc:creator>Xuemin Wang</dc:creator>
		<dc:creator>Mingmin Yang</dc:creator>
		<dc:creator>Xiaoyan Shi</dc:creator>
		<dc:creator>Wenbin Huang</dc:creator>
		<dc:creator>Qing Feng</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12013">
	<title><![CDATA[IJMS, Vol. 14, Pages 12013-12022: Dose-Dependent Protective Effect of Bisperoxovanadium against Acute Cerebral Ischemia in a Rat Model of Ischemia/Reperfusion Injury]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12013</link>
	<description>PTEN (phosphatase and tensin homologue deleted on chromosome 10) is a  dual-specificity lipid and protein phosphatase. The loss of PTEN was originally discovered in numerous human cancers. PTEN inhibition by bisperoxovanadium (bpV) reduces neurological damage after ischemic brain injury. The purpose of this study was to  identify the optimal neuroprotective dose of bpV when administrated after focal ischemia/reperfusion (I/R) injury in rats. Focal I/R injury was induced using the middle cerebral artery occlusion method. bpV at doses of 0.25, 0.50 and 1.0 mg/kg were injected intraperitoneally just after reperfusion, with saline serving as a vehicle control. A maximal reduction in brain injury was observed with 1.0 mg/kg bpV. This dose of bpV also significantly blocked apoptosis in the penumbral cortex of rats. This beneficial effect was associated with the increasing levels of Akt phosphorylation in the penumbral cortex. These results demonstrate that the pharmacological inhibition of PTEN protects against I/R injury in a dose-dependent manner and the protective effect might be induced through upregulation of the phosphoinositide-3 kinase/Akt pro-survival pathway, suggesting a new therapeutic strategy to combat ischemic brain injury.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-05</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140612013</prism:doi>
	<prism:startingPage>12013</prism:startingPage>
		<prism:endingPage>12022</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Dose-Dependent Protective Effect of Bisperoxovanadium against Acute Cerebral Ischemia in a Rat Model of Ischemia/Reperfusion Injury]]></dc:title>
    <dc:date>2013-06-05</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612013</dc:identifier>
    	<dc:creator>Jian-Yi Guo</dc:creator>
		<dc:creator>Jun Ding</dc:creator>
		<dc:creator>Fang Yuan</dc:creator>
		<dc:creator>Hao Chen</dc:creator>
		<dc:creator>Shi-Wen Chen</dc:creator>
		<dc:creator>Heng-Li Tian</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/12004">
	<title><![CDATA[IJMS, Vol. 14, Pages 12004-12012: Interactions between Lactobacillus crispatus and Bacterial Vaginosis (BV)-Associated Bacterial Species in Initial Attachment and Biofilm Formation]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/12004</link>
	<description>Certain anaerobic bacterial species tend to predominate the vaginal flora during bacterial vaginosis (BV), with Gardnerella vaginalis being the most common. However, the exact role of G. vaginalis in BV has not yet been determined. The main goal of  this study was to test the hypothesis that G. vaginalis is an early colonizer, paving the way  for intermediate (e.g., Fusobacterium nucleatum) and late colonizers (e.g.,  Prevotella bivia). Theoretically, in order to function as an early colonizer, species would need to be able to adhere to vaginal epithelium, even in the presence of vaginal lactobacilli. Therefore, we quantified adherence of G. vaginalis and other BV-associated bacteria to an inert surface pre-coated with Lactobacillus crispatus using a new Peptide Nucleic Acid (PNA) Fluorescence In Situ Hybridization (FISH) methodology. We found that  G. vaginalis had the greatest capacity to adhere in the presence of L. crispatus. Theoretically, an early colonizer would contribute to the adherence and/or growth of additional species, so we next quantified the effect of G. vaginalis biofilms on the adherence and growth of other BV-associated species by quantitative Polymerase Chain Reaction (qPCR) technique. Interestingly, G. vaginalis derived a growth benefit from the addition of a second species, regardless of the species. Conversely, G. vaginalis biofilms enhanced the growth of P. bivia, and to a minor extent of F. nucleatum. These results contribute to our understanding of BV biofilm formation and the progression of the disorder.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-05</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:doi>10.3390/ijms140612004</prism:doi>
	<prism:startingPage>12004</prism:startingPage>
		<prism:endingPage>12012</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Interactions between Lactobacillus crispatus and Bacterial Vaginosis (BV)-Associated Bacterial Species in Initial Attachment and Biofilm Formation]]></dc:title>
    <dc:date>2013-06-05</dc:date>
	<dc:identifier>doi: 10.3390/ijms140612004</dc:identifier>
    	<dc:creator>António Machado</dc:creator>
		<dc:creator>Kimberly Jefferson</dc:creator>
		<dc:creator>Nuno Cerca</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11994">
	<title><![CDATA[IJMS, Vol. 14, Pages 11994-12003: Cloning and Polymorphisms of Yak Lactate Dehydrogenase b Gene]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11994</link>
	<description>The main objective of this work was to study the unique polymorphisms of the lactate dehydrogenase-1 (LDH1) gene in yak (Bos grunniens). Native polyacrylamide gel electrophoresis revealed three phenotypes of LDH1 (a tetramer of H subunit) in yak heart and longissimus muscle extracts. The corresponding gene, ldhb, encoding H subunits of three LDH1 phenotypes was obtained by RT-PCR. A total of six nucleotide differences were detected in yak ldhb compared with that of cattle, of which five mutations cause amino acid substitutions. Sequence analysis shows that the G896A and C689A, mutations of ldhb gene, result in alterations of differently charged amino acids, and create the three phenotypes (F, M, and S) of yak LDH1. Molecular modeling of the H subunit of LDH indicates that the substituted amino acids are not located within NAD+ or substrate binding sites. PCR-RFLP examination of G896A mutation demonstrated that most LDH1-F samples are actually heterozygote at this site. These results help to elucidate the molecular basis and genetic characteristic of the three unique LDH1 phenotypes in yak.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-05</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611994</prism:doi>
	<prism:startingPage>11994</prism:startingPage>
		<prism:endingPage>12003</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Cloning and Polymorphisms of Yak Lactate Dehydrogenase b Gene]]></dc:title>
    <dc:date>2013-06-05</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611994</dc:identifier>
    	<dc:creator>Guosheng Wang</dc:creator>
		<dc:creator>Xingbo Zhao</dc:creator>
		<dc:creator>Juming Zhong</dc:creator>
		<dc:creator>Meng Cao</dc:creator>
		<dc:creator>Qinghua He</dc:creator>
		<dc:creator>Zhengxin Liu</dc:creator>
		<dc:creator>Yaqiu Lin</dc:creator>
		<dc:creator>Yaou Xu</dc:creator>
		<dc:creator>Yucai Zheng</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11981">
	<title><![CDATA[IJMS, Vol. 14, Pages 11981-11993: Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP Cells]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11981</link>
	<description>Enhancer of zeste homolog 2 (EZH2) plays a crucial role in embryonic and somatic stem cells for their proliferation and differentiation. However, the roles and underlying mechanisms of EZH2 in prostate cancer stem cells (PCSCs) remain unknown. This study aimed to investigate the effects of EZH2 on PCSCs. PCSCs were isolated from the human prostate cancer cell line LNcap by fluorescence activated cell sorting (FACS). EZH2 expression was compared between PCSCs and non-PCSCs. The association between EZH2 function and PCSC growth was investigated using siRNA-mediated knock-down of EZH2. Cell growth was investigated by MTT, cell cycle and apoptosis of PCSCs were explored by flow cytometric analysis. Finally, the upstream pathway miRNA level was determined via a luciferase reporter assay, and the downstream pathway cycle regulators were examined via reverse transcriptase-polymerase chain reaction. The results showed that LNcap cell line comprised a greater proportion of CD44+/CD133+ cells by comparison to the PC-3 cell line. EZH2 was up-regulated in PCSCs compared with non-PCSCs. Silence of EZH2 inhibited cell growth and the cell cycle and promoted the progression of apoptosis. Furthermore, EZH2 was a direct target of miR-101 in PCSCs and EZH2’s mRNA levels were inversely correlated with miR-101 expression and cyclin E2  (a cell-cycle regulator) was suppressed by siEZH2. In conclusion, EZH2 is essential for PCSC growth, partly through a negative regulation by miR-101 and positively regulating cyclin E2.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-05</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611981</prism:doi>
	<prism:startingPage>11981</prism:startingPage>
		<prism:endingPage>11993</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP Cells]]></dc:title>
    <dc:date>2013-06-05</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611981</dc:identifier>
    	<dc:creator>Kuiqing Li</dc:creator>
		<dc:creator>Cheng Liu</dc:creator>
		<dc:creator>Bangfen Zhou</dc:creator>
		<dc:creator>Liangkuan Bi</dc:creator>
		<dc:creator>Hai Huang</dc:creator>
		<dc:creator>Tianxin Lin</dc:creator>
		<dc:creator>Kewei Xu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11963">
	<title><![CDATA[IJMS, Vol. 14, Pages 11963-11980: In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11963</link>
	<description>By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of patients progress to end-stages of the disease, and the course of the disease progression to the later stages seems to be slow, developing progressively over several years. Key risk factors including overweight, insulin resistance, a sedentary life-style and an altered dietary pattern, as well as genetic factors and disturbances of the intestinal barrier function have been identified in recent years. Despite intense research efforts that lead to the identification of these risk factors, knowledge about disease initiation and molecular mechanisms involved in progression is still limited. This review summarizes diet-induced and genetic animal models, as well as cell culture models commonly used in recent years to add to the understanding of the mechanisms involved in NAFLD, also referring to their advantages and disadvantages.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-05</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611963</prism:doi>
	<prism:startingPage>11963</prism:startingPage>
		<prism:endingPage>11980</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)]]></dc:title>
    <dc:date>2013-06-05</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611963</dc:identifier>
    	<dc:creator>Giridhar Kanuri</dc:creator>
		<dc:creator>Ina Bergheim</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11942">
	<title><![CDATA[IJMS, Vol. 14, Pages 11942-11962: Enhanced Inhibition of Prostate Tumor Growth by Dual Targeting the Androgen Receptor and the Regulatory Subunit Type Iα of Protein Kinase A in Vivo]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11942</link>
	<description>Progression to castration resistance is a major problem in the treatment of advanced prostate cancer and is likely to be driven by activation of several molecular pathways, including androgen receptor (AR) and cyclic AMP-dependent protein kinase A (PKA). In this study, we examined the therapeutic efficacy of a combined inhibition of the AR and the regulatory subunit type Iα (RIα) of protein kinase A with second generation antisense oligonucleotides (ODNs) in androgen-sensitive LNCaP and castration-resistant LNCaPabl tumors in vivo. We found that targeting the AR alone inhibited LNCaP, as well as LNCaPabl tumors. Combined inhibition resulted in an improved response over single targeting and even a complete tumor remission in LNCaPabl. Western blot analysis revealed that both ODNs were effective in reducing their target proteins when administered alone or in combination. In addition, treatment with the ODNs was associated with an induction of apoptosis. Our data suggest that dual targeting of the AR and PKARIα is more effective in inhibiting LNCaP and LNCaPabl tumor growth than single treatment and may give a treatment benefit, especially in castration-resistant prostate cancers.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-04</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611942</prism:doi>
	<prism:startingPage>11942</prism:startingPage>
		<prism:endingPage>11962</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Enhanced Inhibition of Prostate Tumor Growth by Dual Targeting the Androgen Receptor and the Regulatory Subunit Type Iα of Protein Kinase A in Vivo]]></dc:title>
    <dc:date>2013-06-04</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611942</dc:identifier>
    	<dc:creator>Iris Eder</dc:creator>
		<dc:creator>Martina Egger</dc:creator>
		<dc:creator>Hannes Neuwirt</dc:creator>
		<dc:creator>Christof Seifarth</dc:creator>
		<dc:creator>Danilo Maddalo</dc:creator>
		<dc:creator>Andreas Desiniotis</dc:creator>
		<dc:creator>Georg Schäfer</dc:creator>
		<dc:creator>Martin Puhr</dc:creator>
		<dc:creator>Jasmin Bektic</dc:creator>
		<dc:creator>Andrew Cato</dc:creator>
		<dc:creator>Helmut Klocker</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11929">
	<title><![CDATA[IJMS, Vol. 14, Pages 11929-11941: Individual and Joint Impacts of Ethanol Use, BMI,  Age and Gender on Serum Gamma-Glutamyltransferase  Levels in Healthy Volunteers]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11929</link>
	<description>Excessive ethanol consumption, obesity and increasing age may all lead to increased serum levels of gamma-glutamyltransferase (GGT) enzyme, which plays a key role in the metabolism of extracellular reduced glutathione. However, as yet, the interactions between the various modulators of GGT activities have remained poorly defined. We analyzed data from 15,617 apparently healthy individuals (7254 men and 8363 women, mean age 46 ± 13 years, range 25–74 years) who participated in a national cross-sectional health survey in Finland between 1997 and 2007. All subjects underwent detailed clinical examinations and interviews, including the amount of ethanol use and smoking habits. GGT levels were measured from all participants, and the individual and joint impacts of the different study variables on GGT levels were assessed. Significant individual effects were noted for ethanol use (p &amp;amp;lt; 0.001), body mass index (BMI)  (p &amp;amp;lt; 0.001), age (p &amp;amp;lt; 0.001) and smoking (p &amp;amp;lt; 0.001). In men, significant two-factor interactions occurred between ethanol use and age (p &amp;amp;lt; 0.020). Among those over 40 years of age, ethanol consumption was found to be a stronger determinant of increased GGT levels than in men below 40 years, whereas in the latter age group, BMI was found to predominate. In women, a significant two-factor interaction occurred between ethanol and BMI (p = 0.010), whereas it did not with ethanol use and age. The data underscores the role of ethanol consumption and age as major determinants of increased GGT levels in men, whereas in women, a relatively stronger impact was noted for ethanol intake and BMI. In light of the ability of GGT enzyme to modulate crucial redox-sensitive functions, the present findings also support the use of GGT as a biomarker of oxidative stress.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-04</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611929</prism:doi>
	<prism:startingPage>11929</prism:startingPage>
		<prism:endingPage>11941</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Individual and Joint Impacts of Ethanol Use, BMI,  Age and Gender on Serum Gamma-Glutamyltransferase  Levels in Healthy Volunteers]]></dc:title>
    <dc:date>2013-06-04</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611929</dc:identifier>
    	<dc:creator>Joanna Danielsson</dc:creator>
		<dc:creator>Päivikki Kangastupa</dc:creator>
		<dc:creator>Tiina Laatikainen</dc:creator>
		<dc:creator>Mauri Aalto</dc:creator>
		<dc:creator>Onni Niemelä</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11915">
	<title><![CDATA[IJMS, Vol. 14, Pages 11915-11928: Inhibition Effects of a Synthesized Novel 4-Aminoantipyrine Derivative on the Corrosion of Mild Steel in Hydrochloric Acid Solution together with Quantum Chemical Studies]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11915</link>
	<description>1,5-Dimethyl-4-((2-methylbenzylidene)amino)-2-phenyl-1H-pyrazol-3(2H)-one (DMPO) was synthesized to be evaluated as a corrosion inhibitor. The corrosion inhibitory effects of DMPO on mild steel in 1.0 M HCl were investigated using electrochemical impedance spectroscopy (EIS), potentiodynamic polarization, open circuit potential (OCP) and electrochemical frequency modulation (EFM). The results showed that DMPO inhibited mild steel corrosion in acid solution and indicated that the inhibition efficiency increased with increasing inhibitor concentration. Changes in the impedance parameters suggested an adsorption of DMPO onto the mild steel surface, leading to the formation of protective films. The novel synthesized corrosion inhibitor was characterized using  UV-Vis, FT-IR and NMR spectral analyses. Electronic properties such as highest occupied molecular orbital energy, lowest unoccupied molecular orbital energy (EHOMO and ELUMO, respectively) and dipole moment (μ) were calculated and discussed. The results showed that the corrosion inhibition efficiency increased with an increase in the EHOMO values but with a decrease in the ELUMO value.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-04</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611915</prism:doi>
	<prism:startingPage>11915</prism:startingPage>
		<prism:endingPage>11928</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Inhibition Effects of a Synthesized Novel 4-Aminoantipyrine Derivative on the Corrosion of Mild Steel in Hydrochloric Acid Solution together with Quantum Chemical Studies]]></dc:title>
    <dc:date>2013-06-04</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611915</dc:identifier>
    	<dc:creator>Sutiana Junaedi</dc:creator>
		<dc:creator>Ahmed Al-Amiery</dc:creator>
		<dc:creator>Abdulhadi Kadihum</dc:creator>
		<dc:creator>Abdul Kadhum</dc:creator>
		<dc:creator>Abu Mohamad</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11895">
	<title><![CDATA[IJMS, Vol. 14, Pages 11895-11914: Myricetin-Mediated Lifespan Extension in  Caenorhabditis elegans Is Modulated by DAF-16]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11895</link>
	<description>Myricetin is a naturally occurring flavonol found in many plant based food sources. It increases the lifespan of Caenorhabditis elegans, but the molecular mechanisms are not yet fully understood. We have investigated the impact of this flavonoid on the transcription factors DAF-16 (C. elegans FoxO homologue) and SKN-1 (Nrf2 homologue), which have crucial functions in the regulation of ageing. Myricetin is rapidly assimilated by the nematode, causes a nuclear translocation of DAF-16 but not of SKN-1, and finally prolongs the mean adult lifespan of C. elegans by 32.9%. The lifespan prolongation was associated with a decrease in the accumulation of reactive oxygen species (ROS) detected by DCF. Myricetin also decreases the formation of lipofuscin, a pigment consisting of highly oxidized and cross-linked proteins that is considered as a biomarker of ageing in diverse species. The lifespan extension was completely abolished in a daf-16 loss-of-function mutant strain (CF1038). Consistently with this result, myricetin was also not able to diminish stress-induced ROS accumulation in the mutant. These results strongly indicate that the pro-longevity effect of myricetin is dependent on DAF-16 and not on direct anti-oxidative effects of the flavonoid.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-04</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611895</prism:doi>
	<prism:startingPage>11895</prism:startingPage>
		<prism:endingPage>11914</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Myricetin-Mediated Lifespan Extension in  Caenorhabditis elegans Is Modulated by DAF-16]]></dc:title>
    <dc:date>2013-06-04</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611895</dc:identifier>
    	<dc:creator>Christian Büchter</dc:creator>
		<dc:creator>Daniela Ackermann</dc:creator>
		<dc:creator>Susannah Havermann</dc:creator>
		<dc:creator>Sebastian Honnen</dc:creator>
		<dc:creator>Yvonni Chovolou</dc:creator>
		<dc:creator>Gerhard Fritz</dc:creator>
		<dc:creator>Andreas Kampkötter</dc:creator>
		<dc:creator>Wim Wätjen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11871">
	<title><![CDATA[IJMS, Vol. 14, Pages 11871-11894: Use of Heat Stress Responsive Gene Expression Levels for Early Selection of Heat Tolerant Cabbage (Brassica oleracea L.)]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11871</link>
	<description>Cabbage is a relatively robust vegetable at low temperatures. However, at high temperatures, cabbage has disadvantages, such as reduced disease tolerance and lower yields. Thus, selection of heat-tolerant cabbage is an important goal in cabbage breeding. Easier or faster selection of superior varieties of cabbage, which are tolerant to heat and disease and have improved taste and quality, can be achieved with molecular and biological methods. We compared heat-responsive gene expression between a heat-tolerant cabbage line (HTCL), “HO”, and a heat-sensitive cabbage line (HSCL), “JK”, by Genechip assay. Expression levels of specific heat stress-related genes were increased in response to high-temperature stress, according to Genechip assays. We performed quantitative  RT-PCR (qRT-PCR) to compare expression levels of these heat stress-related genes in four HTCLs and four HSCLs. Transcript levels for heat shock protein BoHsp70 and transcription factor BoGRAS (SCL13) were more strongly expressed only in all HTCLs compared to all HSCLs, showing much lower level expressions at the young plant stage under heat stress (HS). Thus, we suggest that expression levels of these genes may be early selection markers for HTCLs in cabbage breeding. In addition, several genes that are involved in the secondary metabolite pathway were differentially regulated in HTCL and HSCL exposed to heat stress.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-04</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611871</prism:doi>
	<prism:startingPage>11871</prism:startingPage>
		<prism:endingPage>11894</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Use of Heat Stress Responsive Gene Expression Levels for Early Selection of Heat Tolerant Cabbage (Brassica oleracea L.)]]></dc:title>
    <dc:date>2013-06-04</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611871</dc:identifier>
    	<dc:creator>Hyun Park</dc:creator>
		<dc:creator>Won Jung</dc:creator>
		<dc:creator>Sang Lee</dc:creator>
		<dc:creator>Jun Song</dc:creator>
		<dc:creator>Suk-Yoon Kwon</dc:creator>
		<dc:creator>HyeRan Kim</dc:creator>
		<dc:creator>ChulWook Kim</dc:creator>
		<dc:creator>Jun Ahn</dc:creator>
		<dc:creator>Hye Cho</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11861">
	<title><![CDATA[IJMS, Vol. 14, Pages 11861-11870: Prevention of Intra-Abdominal Adhesion by Bi-Layer Electrospun Membrane]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11861</link>
	<description>The aim of this study was to compare the anti-adhesion efficacy of a bi-layer electrospun fibrous membrane consisting of hyaluronic acid-loaded poly(ε-caprolactone) (PCL) fibrous membrane as the inner layer and PCL fibrous membrane as the outer layer with a single-layer PCL electrospun fibrous membrane in a rat cecum abrasion model. The rat model utilized a cecal abrasion and abdominal wall insult surgical protocol. The  bi-layer and PCL membranes were applied between the cecum and the abdominal wall, respectively. Control animals did not receive any treatment. After postoperative day 14, a visual semiquantitative grading scale was used to grade the extent of adhesion. Histological analysis was performed to reveal the features of adhesion tissues. Bi-layer membrane treated animals showed significantly lower adhesion scores than control animals (p &amp;amp;lt; 0.05) and a lower adhesion score compared with the PCL membrane. Histological analysis of the bi-layer membrane treated rat rarely demonstrated tissue adhesion while that of the PCL membrane treated rat and control rat showed loose and dense adhesion tissues, respectively. Bi-layer membrane can efficiently prevent adhesion formation in abdominal cavity and showed a significantly decreased adhesion tissue formation compared with the control.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-04</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611861</prism:doi>
	<prism:startingPage>11861</prism:startingPage>
		<prism:endingPage>11870</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Prevention of Intra-Abdominal Adhesion by Bi-Layer Electrospun Membrane]]></dc:title>
    <dc:date>2013-06-04</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611861</dc:identifier>
    	<dc:creator>Shichao Jiang</dc:creator>
		<dc:creator>Wei Wang</dc:creator>
		<dc:creator>Hede Yan</dc:creator>
		<dc:creator>Cunyi Fan</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11842">
	<title><![CDATA[IJMS, Vol. 14, Pages 11842-11860: Peptide Induced Crystallization of Calcium Carbonate on Wrinkle Patterned Substrate: Implications for Chitin Formation in Molluscs]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11842</link>
	<description>We here present the nucleation and growth of calcium carbonate under the influence of synthetic peptides on topographically patterned poly(dimethylsiloxane) (PDMS) substrates, which have a controlled density of defects between the wrinkles. Experiments with two lysine-rich peptides derived from the extracellular conserved domain E22 of the mollusc chitin synthase Ar-CS1, AKKKKKAS (AS8) and EEKKKKKES (ES9) on these substrates showed their influence on the calcium carbonate morphology. A transition from polycrystalline composites to single crystalline phases was achieved with the peptide AS8 by changing the pH of the buffer solution. We analyzed three different pH values as previous experiments showed that E22 interacts with aragonite biominerals more strongly at pH 7.75 than at pH 9.0. At any given pH, crystals appeared in characteristic morphologies only on wrinkled substrates, and did not occur on the flat, wrinkle-free PDMS substrate. These results suggest that these wrinkled substrates could be useful for controlling the morphologies of other mineral/peptide and mineral/protein composites. In nature, these templates are formed enzymatically by glycosyltransferases containing  pH-sensitive epitopes, similar to the peptides investigated here. Our in vitro test systems may be useful to gain understanding of the formation of distinct 3D morphologies in mollusc shells in response to local pH shifts during the mineralization of organic templates.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-04</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611842</prism:doi>
	<prism:startingPage>11842</prism:startingPage>
		<prism:endingPage>11860</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Peptide Induced Crystallization of Calcium Carbonate on Wrinkle Patterned Substrate: Implications for Chitin Formation in Molluscs]]></dc:title>
    <dc:date>2013-06-04</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611842</dc:identifier>
    	<dc:creator>Anindita Sengupta Ghatak</dc:creator>
		<dc:creator>Marcus Koch</dc:creator>
		<dc:creator>Christina Guth</dc:creator>
		<dc:creator>Ingrid Weiss</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11830">
	<title><![CDATA[IJMS, Vol. 14, Pages 11830-11841: Versatile Redox Chemistry Complicates Antioxidant Capacity Assessment: Flavonoids as Milieu-Dependent Anti-  and Pro-Oxidants]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11830</link>
	<description>Some antioxidants have been shown to possess additional pro-oxidant effects. Diverse methodologies exist for studying redox properties of synthetic and natural chemicals. The latter are substantial components of our diet. Exploration of their contribution to life-extending or -compromising effects is mandatory. Among reactive oxygen species (ROS), hydroxyl radical (•OH) is the most damaging species. Due to its short half-life, the assay has to contain a specific generation system. Plants synthesize flavonoids, phenolic compounds recognized as counter-agents to coronary heart disease. Their antioxidant activities are affected by their hydroxylation patterns. Moreover, in the plant, they mainly occur as glycosides. We chose three derivatives, quercetin, luteolin, and rutin, in attempts to explore their redox chemistry in contrasting hydrogen peroxide environments. Initial addition of hydrogen peroxide in high concentration or gradual development constituted a main factor affecting their redox chemical properties, especially in case of quercetin. Our study exemplifies that a combination of a chemical assay (deoxyribose degradation) with an electrochemical method (square-wave voltammetry) provides insightful data. The ambiguity of the tested flavonoids to act either as anti- or  pro-oxidant may complicate categorization, but probably contributed to their evolution as components of a successful metabolic system that benefits both producer and consumer.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-04</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611830</prism:doi>
	<prism:startingPage>11830</prism:startingPage>
		<prism:endingPage>11841</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Versatile Redox Chemistry Complicates Antioxidant Capacity Assessment: Flavonoids as Milieu-Dependent Anti-  and Pro-Oxidants]]></dc:title>
    <dc:date>2013-06-04</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611830</dc:identifier>
    	<dc:creator>Vladimir Chobot</dc:creator>
		<dc:creator>Lenka Kubicova</dc:creator>
		<dc:creator>Gert Bachmann</dc:creator>
		<dc:creator>Franz Hadacek</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11816">
	<title><![CDATA[IJMS, Vol. 14, Pages 11816-11829: Genome-Wide Investigation of Multifocal and Unifocal Prostate Cancer—Are They Genetically Different?]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11816</link>
	<description>Prostate cancer is widely observed to be biologically heterogeneous. Its heterogeneity is manifested histologically as multifocal prostate cancer, which is observed more frequently than unifocal prostate cancer. The clinical and prognostic significance of either focal cancer type is not fully established. To investigate prostate cancer heterogeneity, the genetic profiles of multifocal and unifocal prostate cancers were compared. Here, we report observations deduced from tumor-tumor comparison of copy number alteration data of both focal categories. Forty-one fresh frozen prostate cancer foci from 14 multifocal prostate cancers and eight unifocal prostate cancers were subjected to copy number variation analysis with the Affymetrix SNP 6.0 microarray tool. With the investigated cases, tumors obtained from a single prostate exhibited different genetic profiles of variable degrees. Further comparison identified no distinct genetic pattern or signatures specific to multifocal or unifocal prostate cancer. Our findings suggest that samples obtained from multiple sites of a single unifocal prostate cancer show as much genetic heterogeneity and variability as separate tumors obtained from a single multifocal  prostate cancer.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-03</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611816</prism:doi>
	<prism:startingPage>11816</prism:startingPage>
		<prism:endingPage>11829</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Genome-Wide Investigation of Multifocal and Unifocal Prostate Cancer—Are They Genetically Different?]]></dc:title>
    <dc:date>2013-06-03</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611816</dc:identifier>
    	<dc:creator>Chinyere Ibeawuchi</dc:creator>
		<dc:creator>Hartmut Schmidt</dc:creator>
		<dc:creator>Reinhard Voss</dc:creator>
		<dc:creator>Ulf Titze</dc:creator>
		<dc:creator>Mahmoud Abbas</dc:creator>
		<dc:creator>Joerg Neumann</dc:creator>
		<dc:creator>Elke Eltze</dc:creator>
		<dc:creator>Agnes Hoogland</dc:creator>
		<dc:creator>Guido Jenster</dc:creator>
		<dc:creator>Burkhard Brandt</dc:creator>
		<dc:creator>Axel Semjonow</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11795">
	<title><![CDATA[IJMS, Vol. 14, Pages 11795-11815: Photochemical Production and Behavior of Hydroperoxyacids in Heterotrophic Bacteria Attached to Senescent Phytoplanktonic Cells]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11795</link>
	<description>The photooxidation of cellular monounsaturated fatty acids was investigated in senescent phytoplanktonic cells (Emiliania huxleyi) and in their attached bacteria under laboratory controlled conditions. Our results indicated that UV-visible irradiation of phytodetritus induced the photooxidation of oleic (produced by phytoplankton and bacteria) and cis-vaccenic (specifically produced by bacteria) acids. These experiments confirmed the involvement of a substantial singlet oxygen transfer from senescent phytoplanktonic cells to attached bacteria, and revealed a significant correlation between the concentration of chlorophyll, a photosensitizer, in the phytodetritus and the photodegradation state of bacteria. Hydroperoxyacids (fatty acid photoproducts) appeared to be quickly degraded to ketoacids and hydroxyacids in bacteria and in phytoplanktonic cells. This degradation involves homolytic cleavage (most likely induced by UV and/or transition metal ions) and peroxygenase activity (yielding epoxy acids).</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-03</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611795</prism:doi>
	<prism:startingPage>11795</prism:startingPage>
		<prism:endingPage>11815</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Photochemical Production and Behavior of Hydroperoxyacids in Heterotrophic Bacteria Attached to Senescent Phytoplanktonic Cells]]></dc:title>
    <dc:date>2013-06-03</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611795</dc:identifier>
    	<dc:creator>Morgan Petit</dc:creator>
		<dc:creator>Richard Sempéré</dc:creator>
		<dc:creator>Frédéric Vaultier</dc:creator>
		<dc:creator>Jean-François Rontani</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11767">
	<title><![CDATA[IJMS, Vol. 14, Pages 11767-11794: Phospholipids at the Interface: Current Trends and Challenges]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11767</link>
	<description>Phospholipids are one of the major structural elements of biological membranes. Due to their amphiphilic character, they can adopt various molecular assemblies when dispersed in water, such as bilayer vesicles or micelles, which give them unique interfacial properties and render them very attractive in terms of foam or emulsion stabilization. This article aims at reviewing the properties of phospholipids at the air/water and oil/water interfaces, as well as the recent advances in using these natural components as stabilizers, alone or in combination with other compounds such as proteins. A discussion regarding the challenges and opportunities offered by phospholipids-stabilized structure concludes  the review.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-06-03</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611767</prism:doi>
	<prism:startingPage>11767</prism:startingPage>
		<prism:endingPage>11794</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Phospholipids at the Interface: Current Trends and Challenges]]></dc:title>
    <dc:date>2013-06-03</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611767</dc:identifier>
    	<dc:creator>Roman Pichot</dc:creator>
		<dc:creator>Richard Watson</dc:creator>
		<dc:creator>Ian Norton</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11742">
	<title><![CDATA[IJMS, Vol. 14, Pages 11742-11766: Modulation by Melatonin of the Pathogenesis of Inflammatory Autoimmune Diseases]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11742</link>
	<description>Melatonin is the major secretory product of the pineal gland during the night and has multiple activities including the regulation of circadian and seasonal rhythms, and antioxidant and anti-inflammatory effects. It also possesses the ability to modulate immune responses by regulation of the T helper 1/2 balance and cytokine production. Autoimmune diseases, which result from the activation of immune cells by autoantigens released from normal tissues, affect around 5% of the population. Activation of autoantigen-specific immune cells leads to subsequent damage of target tissues by these activated cells. Melatonin therapy has been investigated in several animal models of autoimmune disease, where it has a beneficial effect in a number of models excepting rheumatoid arthritis, and has been evaluated in clinical autoimmune diseases including rheumatoid arthritis and ulcerative colitis. This review summarizes and highlights the role and the modulatory effects of melatonin in several inflammatory autoimmune diseases including multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes mellitus, and inflammatory bowel disease.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-31</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611742</prism:doi>
	<prism:startingPage>11742</prism:startingPage>
		<prism:endingPage>11766</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Modulation by Melatonin of the Pathogenesis of Inflammatory Autoimmune Diseases]]></dc:title>
    <dc:date>2013-05-31</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611742</dc:identifier>
    	<dc:creator>Gu-Jiun Lin</dc:creator>
		<dc:creator>Shing-Hwa Huang</dc:creator>
		<dc:creator>Shyi-Jou Chen</dc:creator>
		<dc:creator>Chih-Hung Wang</dc:creator>
		<dc:creator>Deh-Ming Chang</dc:creator>
		<dc:creator>Huey-Kang Sytwu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11713">
	<title><![CDATA[IJMS, Vol. 14, Pages 11713-11741: Towards a Molecular Understanding of the Biosynthesis  of Amaryllidaceae Alkaloids in Support of Their  Expanding Medical Use]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11713</link>
	<description>The alkaloids characteristically produced by the subfamily Amaryllidoideae of the Amaryllidaceae, bulbous plant species that include well know genera such as Narcissus (daffodils) and Galanthus (snowdrops), are a source of new pharmaceutical compounds. Presently, only the Amaryllidaceae alkaloid galanthamine, an acetylcholinesterase inhibitor used to treat symptoms of Alzheimer’s disease, is produced commercially as a drug from cultivated plants. However, several Amaryllidaceae alkaloids have shown great promise as anti-cancer drugs, but their further clinical development is restricted by their limited commercial availability. Amaryllidaceae species have a long history of cultivation and breeding as ornamental bulbs, and phytochemical research has focussed on the diversity in alkaloid content and composition. In contrast to the available pharmacological and phytochemical data, ecological, physiological and molecular aspects of the Amaryllidaceae and their alkaloids are much less explored and the identity of the alkaloid biosynthetic genes is presently unknown. An improved molecular understanding of Amaryllidaceae alkaloid biosynthesis would greatly benefit the rational design of breeding programs to produce cultivars optimised for the production of pharmaceutical compounds and enable biotechnology based approaches.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-31</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611713</prism:doi>
	<prism:startingPage>11713</prism:startingPage>
		<prism:endingPage>11741</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Towards a Molecular Understanding of the Biosynthesis  of Amaryllidaceae Alkaloids in Support of Their  Expanding Medical Use]]></dc:title>
    <dc:date>2013-05-31</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611713</dc:identifier>
    	<dc:creator>Adam Takos</dc:creator>
		<dc:creator>Fred Rook</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11692">
	<title><![CDATA[IJMS, Vol. 14, Pages 11692-11712: Wharton’s Jelly-Derived Mesenchymal Stem Cells:  Phenotypic Characterization and Optimizing Their  Therapeutic Potential for Clinical Applications]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11692</link>
	<description>Wharton’s jelly (WJ) is a gelatinous tissue within the umbilical cord that contains myofibroblast-like stromal cells. A unique cell population of WJ that has been suggested as displaying the stemness phenotype is the mesenchymal stromal cells (MSCs). Because MSCs’ stemness and immune properties appear to be more robustly expressed and functional which are more comparable with fetal than adult-derived MSCs, MSCs harvested from the “young” WJ are considered much more proliferative, immunosuppressive, and even therapeutically active stem cells than those isolated from older, adult tissue sources such as the bone marrow or adipose. The present review discusses the phenotypic characteristics, therapeutic applications, and optimization of experimental protocols for WJ-derived stem cells. MSCs derived from WJ display promising transplantable features, including ease  of sourcing, in vitro expandability, differentiation abilities, immune-evasion and  immune-regulation capacities. Accumulating evidence demonstrates that WJ-derived stem cells possess many potential advantages as transplantable cells for treatment of various diseases (e.g., cancer, chronic liver disease, cardiovascular diseases, nerve, cartilage and tendon injury). Additional studies are warranted to translate the use of WJ-derived stem cells for clinical applications.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-31</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611692</prism:doi>
	<prism:startingPage>11692</prism:startingPage>
		<prism:endingPage>11712</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Wharton’s Jelly-Derived Mesenchymal Stem Cells:  Phenotypic Characterization and Optimizing Their  Therapeutic Potential for Clinical Applications]]></dc:title>
    <dc:date>2013-05-31</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611692</dc:identifier>
    	<dc:creator>Dae-Won Kim</dc:creator>
		<dc:creator>Meaghan Staples</dc:creator>
		<dc:creator>Kazutaka Shinozuka</dc:creator>
		<dc:creator>Paolina Pantcheva</dc:creator>
		<dc:creator>Sung-Don Kang</dc:creator>
		<dc:creator>Cesar Borlongan</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11643">
	<title><![CDATA[IJMS, Vol. 14, Pages 11643-11691: An Overview of Biological Macromolecule Crystallization]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11643</link>
	<description>The elucidation of the three dimensional structure of biological macromolecules has provided an important contribution to our current understanding of many basic mechanisms involved in life processes. This enormous impact largely results from the ability of X-ray crystallography to provide accurate structural details at atomic resolution that are a prerequisite for a deeper insight on the way in which bio-macromolecules interact with each other to build up supramolecular nano-machines capable of performing specialized biological functions. With the advent of high-energy synchrotron sources and the development of sophisticated software to solve X-ray and neutron crystal structures of large molecules, the crystallization step has become even more the bottleneck of a successful structure determination. This review introduces the general aspects of protein crystallization, summarizes conventional and innovative crystallization methods and focuses on the new strategies utilized to improve the success rate of experiments and increase crystal diffraction quality.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-31</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611643</prism:doi>
	<prism:startingPage>11643</prism:startingPage>
		<prism:endingPage>11691</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[An Overview of Biological Macromolecule Crystallization]]></dc:title>
    <dc:date>2013-05-31</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611643</dc:identifier>
    	<dc:creator>Irene Russo Krauss</dc:creator>
		<dc:creator>Antonello Merlino</dc:creator>
		<dc:creator>Alessandro Vergara</dc:creator>
		<dc:creator>Filomena Sica</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11626">
	<title><![CDATA[IJMS, Vol. 14, Pages 11626-11642: Epidermal Stem Cells in Orthopaedic Regenerative Medicine]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11626</link>
	<description>In the last decade, great advances have been made in epidermal stem cell  studies at the cellular and molecular level. These studies reported various subpopulations and differentiations existing in the epidermal stem cell. Although controversies and unknown issues remain, epidermal stem cells possess an immune-privileged property in transplantation together with easy accessibility, which is favorable for future clinical application. In this review, we will summarize the biological characteristics of epidermal stem cells, and their potential in orthopedic regenerative medicine. Epidermal stem cells play a critical role via cell replacement, and demonstrate significant translational potential in the treatment of orthopedic injuries and diseases, including treatment for wound healing, peripheral nerve and spinal cord injury, and even muscle and bone remodeling.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-31</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611626</prism:doi>
	<prism:startingPage>11626</prism:startingPage>
		<prism:endingPage>11642</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Epidermal Stem Cells in Orthopaedic Regenerative Medicine]]></dc:title>
    <dc:date>2013-05-31</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611626</dc:identifier>
    	<dc:creator>Jin Li</dc:creator>
		<dc:creator>Gehua Zhen</dc:creator>
		<dc:creator>Shin-Yi Tsai</dc:creator>
		<dc:creator>Xiaofeng Jia</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11607">
	<title><![CDATA[IJMS, Vol. 14, Pages 11607-11625: The Physiological Importance of Glucosinolates on Plant Response to Abiotic Stress in Brassica]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11607</link>
	<description>Glucosinolates, a class of secondary metabolites, mainly found in Brassicaceae, are affected by the changing environment. This review is focusing on the physiological significance of glucosinolates and their hydrolysis products in the plant response to different abiotic stresses. Special attention is paid to the crosstalk between some of the physiological processes involved in stress response and glucosinolate metabolism, with the resulting connection between both pathways in which signaling mechanisms glucosinolate may act as signals themselves. The function of glucosinolates, further than in defense switching, is discussed in terms of alleviating pathogen attack under abiotic stress. The fact that the exogenous addition of glucosinolate hydrolysis products may alleviate certain stress conditions through its effect on specific proteins is described in light of the recent reports, but the molecular mechanisms involved in this response merit further research. Finally, the transient allocation and re-distribution of glucosinolates as a response to environmental changes is summarized.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-30</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611607</prism:doi>
	<prism:startingPage>11607</prism:startingPage>
		<prism:endingPage>11625</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[The Physiological Importance of Glucosinolates on Plant Response to Abiotic Stress in Brassica]]></dc:title>
    <dc:date>2013-05-30</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611607</dc:identifier>
    	<dc:creator>María del Carmen Martínez-Ballesta</dc:creator>
		<dc:creator>Diego Moreno</dc:creator>
		<dc:creator>Micaela Carvajal</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11560">
	<title><![CDATA[IJMS, Vol. 14, Pages 11560-11606: MicroRNA-Regulated Protein-Protein Interaction Networks and Their Functions in Breast Cancer]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11560</link>
	<description>MicroRNAs, which are small endogenous RNA regulators, have been associated with various types of cancer. Breast cancer is a major health threat for women worldwide. Many miRNAs were reported to be associated with the progression and carcinogenesis of breast cancer. In this study, we aimed to discover novel breast cancer-related miRNAs  and to elucidate their functions. First, we identified confident miRNA-target pairs by combining data from miRNA target prediction databases and expression profiles of miRNA and mRNA. Then, miRNA-regulated protein interaction networks (PINs) were constructed with confident pairs and known interaction data in the human protein reference database (HPRD). Finally, the functions of miRNA-regulated PINs were elucidated by functional enrichment analysis. From the results, we identified some previously reported breast cancer-related miRNAs and functions of the PINs, e.g., miR-125b, miR-125a,  miR-21, and miR-497. Some novel miRNAs without known association to breast cancer were also found, and the putative functions of their PINs were also elucidated. These include miR-139 and miR-383. Furthermore, we validated our results by receiver operating characteristic (ROC) curve analysis using our miRNA expression profile data, gene expression-based outcome for breast cancer online (GOBO) survival analysis, and a literature search. Our results may provide new insights for research in breast cancer-associated miRNAs.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-30</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611560</prism:doi>
	<prism:startingPage>11560</prism:startingPage>
		<prism:endingPage>11606</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[MicroRNA-Regulated Protein-Protein Interaction Networks and Their Functions in Breast Cancer]]></dc:title>
    <dc:date>2013-05-30</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611560</dc:identifier>
    	<dc:creator>Chia-Hsien Lee</dc:creator>
		<dc:creator>Wen-Hong Kuo</dc:creator>
		<dc:creator>Chen-Ching Lin</dc:creator>
		<dc:creator>Yen-Jen Oyang</dc:creator>
		<dc:creator>Hsuan-Cheng Huang</dc:creator>
		<dc:creator>Hsueh-Fen Juan</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11544">
	<title><![CDATA[IJMS, Vol. 14, Pages 11544-11559: Apparent Polyploidization after Gamma Irradiation:  Pitfalls in the Use of Quantitative Polymerase Chain Reaction (qPCR) for the Estimation of Mitochondrial and Nuclear DNA Gene Copy Numbers]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11544</link>
	<description>Quantitative polymerase chain reaction (qPCR) has been widely used to quantify changes in gene copy numbers after radiation exposure. Here, we show that gamma irradiation ranging from 10 to 100 Gy of cells and cell-free DNA samples significantly affects the measured qPCR yield, due to radiation-induced fragmentation of the DNA template and, therefore, introduces errors into the estimation of gene copy numbers. The radiation-induced DNA fragmentation and, thus, measured qPCR yield varies with temperature not only in living cells, but also in isolated DNA irradiated under cell-free conditions. In summary, the variability in measured qPCR yield from irradiated samples introduces a significant error into the estimation of both mitochondrial and nuclear gene copy numbers and may give spurious evidence for polyploidization.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-30</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Communication</prism:section>
	<prism:doi>10.3390/ijms140611544</prism:doi>
	<prism:startingPage>11544</prism:startingPage>
		<prism:endingPage>11559</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Apparent Polyploidization after Gamma Irradiation:  Pitfalls in the Use of Quantitative Polymerase Chain Reaction (qPCR) for the Estimation of Mitochondrial and Nuclear DNA Gene Copy Numbers]]></dc:title>
    <dc:date>2013-05-30</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611544</dc:identifier>
    	<dc:creator>Winnie Kam</dc:creator>
		<dc:creator>Vanessa Lake</dc:creator>
		<dc:creator>Connie Banos</dc:creator>
		<dc:creator>Justin Davies</dc:creator>
		<dc:creator>Richard Banati</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11527">
	<title><![CDATA[IJMS, Vol. 14, Pages 11527-11543: The Influence of Light Quality, Circadian Rhythm,  and Photoperiod on the CBF-Mediated Freezing Tolerance]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11527</link>
	<description>Low temperature adversely affects crop yields by restraining plant growth and productivity. Most temperate plants have the potential to increase their freezing tolerance upon exposure to low but nonfreezing temperatures, a process known as cold acclimation. Various physiological, molecular, and metabolic changes occur during cold acclimation, which suggests that the plant cold stress response is a complex, vital phenomenon that involves more than one pathway. The C-Repeat Binding Factor (CBF) pathway is the most important and well-studied cold regulatory pathway that imparts freezing tolerance to plants. The regulation of freezing tolerance involves the action of phytochromes, which play an important role in light-mediated signalling to activate cold-induced gene expression through the CBF pathway. Under normal temperature conditions, CBF expression is regulated by the circadian clock through the action of a central oscillator and also day length (photoperiod). The phytochrome and phytochrome interacting factor are involved in the repression of the CBF expression under long day (LD) conditions. Apart from the CBF regulon, a novel pathway involving the Z-box element also mediates the cold acclimation response in a light-dependent manner. This review provides insights into  the progress of cold acclimation in relation to light quality, circadian regulation, and photoperiodic regulation and also explains the underlying molecular mechanisms  of cold acclimation for introducing the engineering of economically important,  cold-tolerant plants.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-30</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611527</prism:doi>
	<prism:startingPage>11527</prism:startingPage>
		<prism:endingPage>11543</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[The Influence of Light Quality, Circadian Rhythm,  and Photoperiod on the CBF-Mediated Freezing Tolerance]]></dc:title>
    <dc:date>2013-05-30</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611527</dc:identifier>
    	<dc:creator>Punyakishore Maibam</dc:creator>
		<dc:creator>Ganesh Nawkar</dc:creator>
		<dc:creator>Joung Park</dc:creator>
		<dc:creator>Vaidurya Sahi</dc:creator>
		<dc:creator>Sang Lee</dc:creator>
		<dc:creator>Chang Kang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11510">
	<title><![CDATA[IJMS, Vol. 14, Pages 11510-11526: SAHBNET, an Accessible Surface-Based Elastic Network:  An Application to Membrane Protein]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11510</link>
	<description>Molecular Dynamics is a method of choice for membrane simulations and the rising of coarse-grained forcefields has opened the way to longer simulations with reduced calculations times. Here, we present an elastic network, SAHBNET (Surface Accessibility Hydrogen-Bonds elastic NETwork), that will maintain the structure of soluble or membrane proteins based on the hydrogen bonds present in the atomistic structure and the proximity between buried residues. This network is applied on the coarse-grained beads defined by the MARTINI model, and was designed to be more physics-based than a simple elastic network. The SAHBNET model is evaluated against atomistic simulations, and compared with ELNEDYN models. The SAHBNET is then used to simulate two membrane proteins inserted in complex lipid bilayers. These bilayers are formed by  self-assembly and the use of a modified version of the GROMACS tool genbox (which is accessible through the gcgs.gembloux.ulg.ac.be website). The results show that SAHBNET keeps the structure close to the atomistic one and is successfully used for the simulation of membrane proteins.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-30</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611510</prism:doi>
	<prism:startingPage>11510</prism:startingPage>
		<prism:endingPage>11526</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[SAHBNET, an Accessible Surface-Based Elastic Network:  An Application to Membrane Protein]]></dc:title>
    <dc:date>2013-05-30</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611510</dc:identifier>
    	<dc:creator>Nicolas Dony</dc:creator>
		<dc:creator>Jean Crowet</dc:creator>
		<dc:creator>Bernard Joris</dc:creator>
		<dc:creator>Robert Brasseur</dc:creator>
		<dc:creator>Laurence Lins</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11496">
	<title><![CDATA[IJMS, Vol. 14, Pages 11496-11509: Optimization of Synthesis Parameters for Mesoporous Shell Formation on Magnetic Nanocores and Their Application as Nanocarriers for Docetaxel Cancer Drug]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11496</link>
	<description>In this work, Fe3O4@SiO2 nanoparticles were coated with mesoporous silica shell by S−N+I− pathway by using anionic surfactant (S−) and co-structure directing agent (N+). The role of co-structure directing agent (CSDA) is to assist the electrostatic interaction between negatively charged silica layers and the negatively charged surfactant molecules. Prior to the mesoporous shell formation step, magnetic cores were coated with a dense silica layer to prevent iron oxide cores from leaching into the mother system under any acidic circumstances. However, it was found that both dense and mesoporous coating parameters affect the textural properties of the produced mesoporous silica shell (i.e., surface area, pore volume and shell thickness). The synthesized Fe3O4@SiO2@m-SiO2 (MCMSS) nanoparticles have been characterized by low-angle X-ray diffraction, transmission electron microscopy (TEM), and N2 adsorption-desorption analysis, and magnetic properties. The synthesized particles had dense and mesoporous silica shells of 8–37 nm and 26–50 nm, respectively. Furthermore, MCMSS possessed surface area of ca. 259–621 m2·g−1, and pore volume of ca. 0.216–0.443 cc·g−1. MCMSS showed docetaxcel cancer drug storage capacity of 25–33 w/w% and possessed control release from their mesochannels which suggest them as proper nanocarriers for docetaxcel molecules.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-30</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611496</prism:doi>
	<prism:startingPage>11496</prism:startingPage>
		<prism:endingPage>11509</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Optimization of Synthesis Parameters for Mesoporous Shell Formation on Magnetic Nanocores and Their Application as Nanocarriers for Docetaxel Cancer Drug]]></dc:title>
    <dc:date>2013-05-30</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611496</dc:identifier>
    	<dc:creator>Ahmed El-Toni</dc:creator>
		<dc:creator>Mohamed Ibrahim</dc:creator>
		<dc:creator>Joselito Labis</dc:creator>
		<dc:creator>Aslam Khan</dc:creator>
		<dc:creator>Mansour Alhoshan</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11484">
	<title><![CDATA[IJMS, Vol. 14, Pages 11484-11495: Reference Gene Selection for Quantitative PCR Studies in  Sheep Neutrophils]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11484</link>
	<description>Reference genes are essential for studying mRNA expression with quantitative PCR (qPCR). We investigated 11 potential neutrophil reference genes (RPL19, GAPDH, ACTB, B2M, HPRT, G6PD, TFRC, PGK1, YWHAZ, SDHA and GYPC) for sheep under disease conditions of foot rot (FR) and with or without Se supplementation. Initial screening was based on gene expression level (&amp;amp;lt;28 Cq cycles) and variability (SD &amp;amp;lt; 1.5 Cq cycles) and excluded TFRC, GYPC and HPRT from further analysis. Expression stability of the remaining genes was evaluated using four software programs: geNorm, NormFinder, BestKeeper and the comparative delta Cq method. The neutrophil reference genes, G6PD, YWHAZ, GAPDH, RPL19 and SDHA, consistently ranked among the top five most stable genes under these experimental conditions. The SDHA gene expression was not stable in FR-diseased sheep receiving Se treatment and, thus, cannot be recommended as a reference gene. The commonly used genes, PGK1, ACTB and B2M, were not reliable reference genes, underscoring the need to validate neutrophil reference genes under different experimental conditions. Multiple references genes rather than a single gene may provide more robust and reliable results. The best pair of reference genes was SDHA/G6PD in healthy sheep and GADPH/YWHAZ in FR-diseased sheep.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-30</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611484</prism:doi>
	<prism:startingPage>11484</prism:startingPage>
		<prism:endingPage>11495</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Reference Gene Selection for Quantitative PCR Studies in  Sheep Neutrophils]]></dc:title>
    <dc:date>2013-05-30</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611484</dc:identifier>
    	<dc:creator>William Vorachek</dc:creator>
		<dc:creator> Hugejiletu</dc:creator>
		<dc:creator>Gerd Bobe</dc:creator>
		<dc:creator>Jean Hall</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11444">
	<title><![CDATA[IJMS, Vol. 14, Pages 11444-11483: Silicon Era of Carbon-Based Life: Application of Genomics and Bioinformatics in Crop Stress Research]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11444</link>
	<description>Abiotic and biotic stresses lead to massive reprogramming of different life processes and are the major limiting factors hampering crop productivity. Omics-based research platforms allow for a holistic and comprehensive survey on crop stress responses and hence may bring forth better crop improvement strategies. Since high-throughput approaches generate considerable amounts of data, bioinformatics tools will play an essential role in storing, retrieving, sharing, processing, and analyzing them. Genomic and functional genomic studies in crops still lag far behind similar studies in humans and other animals. In this review, we summarize some useful genomics and bioinformatics resources available to crop scientists. In addition, we also discuss the major challenges and advancements in the “-omics” studies, with an emphasis on their possible impacts on crop stress research and crop improvement.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-29</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611444</prism:doi>
	<prism:startingPage>11444</prism:startingPage>
		<prism:endingPage>11483</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Silicon Era of Carbon-Based Life: Application of Genomics and Bioinformatics in Crop Stress Research]]></dc:title>
    <dc:date>2013-05-29</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611444</dc:identifier>
    	<dc:creator>Man-Wah Li</dc:creator>
		<dc:creator>Xinpeng Qi</dc:creator>
		<dc:creator>Meng Ni</dc:creator>
		<dc:creator>Hon-Ming Lam</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11438">
	<title><![CDATA[IJMS, Vol. 14, Pages 11438-11443: Editorial of the Special Issue: Signaling Molecules and Signal Transduction in Cells]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11438</link>
	<description>In the special issue “Signaling Molecules and Signal Transduction in Cells” authors were invited to submit papers regarding important and novel aspects of extra- and intracellular signaling which have implications on physiological and pathophysiological processes. These aspects included compounds which are involved in these processes, elucidation of signaling pathways, as well as novel techniques for the analysis of  signaling pathways. In response, various novel and important topics are elucidated in this  special issue.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-29</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:doi>10.3390/ijms140611438</prism:doi>
	<prism:startingPage>11438</prism:startingPage>
		<prism:endingPage>11443</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Editorial of the Special Issue: Signaling Molecules and Signal Transduction in Cells]]></dc:title>
    <dc:date>2013-05-29</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611438</dc:identifier>
    	<dc:creator>Jens Schlossmann</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11424">
	<title><![CDATA[IJMS, Vol. 14, Pages 11424-11437: Notch Signaling Pathway Is Activated in Motoneurons of Spinal Muscular Atrophy]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11424</link>
	<description>Spinal muscular atrophy (SMA) is a neurodegenerative disease produced by low levels of Survival Motor Neuron (SMN) protein that affects alpha motoneurons in the spinal cord. Notch signaling is a cell-cell communication system well known as a master regulator of neural development, but also with important roles in the adult central nervous system. Aberrant Notch function is associated with several developmental neurological disorders; however, the potential implication of the Notch pathway in SMA pathogenesis has not been studied yet. We report here that SMN deficiency, induced in the astroglioma cell line U87MG after lentiviral transduction with a shSMN construct, was associated with an increase in the expression of the main components of Notch signaling pathway, namely its ligands, Jagged1 and Delta1, the Notch receptor and its active intracellular form (NICD). In the SMNΔ7 mouse model of SMA we also found increased astrocyte processes positive for Jagged1 and Delta1 in intimate contact with lumbar spinal cord motoneurons. In these motoneurons an increased Notch signaling was found, as denoted by increased NICD levels and reduced expression of the proneural gene neurogenin 3, whose transcription is negatively regulated by Notch. Together, these findings may be relevant to understand some pathologic attributes of SMA motoneurons.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-29</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611424</prism:doi>
	<prism:startingPage>11424</prism:startingPage>
		<prism:endingPage>11437</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Notch Signaling Pathway Is Activated in Motoneurons of Spinal Muscular Atrophy]]></dc:title>
    <dc:date>2013-05-29</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611424</dc:identifier>
    	<dc:creator>Víctor Caraballo-Miralles</dc:creator>
		<dc:creator>Andrea Cardona-Rossinyol</dc:creator>
		<dc:creator>Ana Garcera</dc:creator>
		<dc:creator>Laura Torres-Benito</dc:creator>
		<dc:creator>Rosa Soler</dc:creator>
		<dc:creator>Lucía Tabares</dc:creator>
		<dc:creator>Jerònia Lladó</dc:creator>
		<dc:creator>Gabriel Olmos</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11402">
	<title><![CDATA[IJMS, Vol. 14, Pages 11402-11423: Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11402</link>
	<description>Monoclonal antibody G250 (mAbG250) recognizes a determinant on carbonic anhydrase IX (CAIX). CAIX is expressed by virtually all renal cell carcinomas of the clear cell type (ccRCC), but expression in normal tissues is restricted. The homogeneous CAIX expression in ccRCC and excellent targeting capability of mAbG250 in animal models led to the initiation of the clinical evaluation of mAbG250 in (metastatic) RCC (mRCC) patients. Clinical studies confirmed the outstanding targeting ability of mAbG250 and cG250 PET imaging, as diagnostic modality holds great promise for the future, both in detecting localized and advanced disease. Confirmation of the results obtained in the  non-randomized clinical trials with unmodified cG250 is needed to substantiate the value of cG250 treatment in mRCC. cG250-Based radio immuno-therapy (RIT) holds promise for treatment of patients with small-volume disease, and adjuvant treatment with unmodified cG250 may be of value in selected cases. In the upcoming years, ongoing clinical trials should provide evidence for these assumptions. Lastly, whether cG250-based RIT can be combined with tyrosine kinase inhibitors, which constitutes the current standard treatment for mRCC, needs to be established.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-29</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611402</prism:doi>
	<prism:startingPage>11402</prism:startingPage>
		<prism:endingPage>11423</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma]]></dc:title>
    <dc:date>2013-05-29</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611402</dc:identifier>
    	<dc:creator>Jeannette Oosterwijk-Wakka</dc:creator>
		<dc:creator>Otto Boerman</dc:creator>
		<dc:creator>Peter Mulders</dc:creator>
		<dc:creator>Egbert Oosterwijk</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11392">
	<title><![CDATA[IJMS, Vol. 14, Pages 11392-11401: The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11392</link>
	<description>The -173 G/C polymorphism in the macrophage migration inhibitory factor (MIF) gene has been implicated in susceptibility to inflammatory bowel disease (IBD), but the results are inconclusive. The present meta-analysis aimed to investigate the overall association between the -173 G/C polymorphism and IBD risk. We searched in Pubmed, and Embase for studies evaluating the association between the -173G/C gene polymorphism and IBD risk. Data were extracted and statistical analysis was performed using Revman 5.1 and STATA 12.0 software. A total of seven publications involving 4729 subjects (2282 IBD cases and 2447 controls) were included in this meta-analysis. Combined analysis revealed a clear association between this polymorphism and IBD susceptibility (OR = 1.48, 95% CI: 1.10–2.00, p = 0.009 for CC vs. CG + GG). Subgroup analysis by ethnicity showed that the IBD risk associated with the -173G/C gene polymorphism was significantly elevated among Asians (OR = 1.79, 95% CI: 1.08–2.96, p = 0.02), but not among Caucasians. Subgroup analysis by disease suggested that the -173G/C gene polymorphism is a risk factor for ulcerative colitis (OR = 1.62, 95% CI: 1.10–2.37, p = 0.01), but that it was not associated with Crohn’s disease. This meta-analysis suggests that the -173 G/C polymorphism in the macrophage MIF gene contributes to IBD susceptibility, specifically in Asian populations. Further studies are needed to validate these findings.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-28</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611392</prism:doi>
	<prism:startingPage>11392</prism:startingPage>
		<prism:endingPage>11401</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis]]></dc:title>
    <dc:date>2013-05-28</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611392</dc:identifier>
    	<dc:creator>Yongchun Shen</dc:creator>
		<dc:creator>Shujin Guo</dc:creator>
		<dc:creator>Ting Yang</dc:creator>
		<dc:creator>Liuqun Jia</dc:creator>
		<dc:creator>Lei Chen</dc:creator>
		<dc:creator>Jing An</dc:creator>
		<dc:creator>Tao Wang</dc:creator>
		<dc:creator>Fuqiang Wen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11376">
	<title><![CDATA[IJMS, Vol. 14, Pages 11376-11391: The Uneven Rate of the Molecular Evolution of Gene Sequences of DNA-Dependent RNA Polymerase I of the Genus Lamium L.]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11376</link>
	<description>RNA polymerase type I (plastid-encoded polymerase, PEP) is one of the key chloroplast enzymes. However, the rpo genes that encode its subunits (rpoA, rpoB, rpoC1 and rpoC2) are relatively rapidly evolving sequences. The aim of this study was to investigate the rate of the molecular evolution of rpo genes and to evaluate them as phylogenetic markers on the example of the genus Lamium L. (Lamiaceae). The analyzed genes were shown to differ in the level of variation, rate of intragenic mutations, phylogenetic informativeness, and in the impact of these mutations on the properties of encoded peptides. Destabilizing effects of the positive pressure were observed in all genes examined coding for PEP enzyme. We have demonstrated the relationship between mutations fixed by positive selection and the separation of phylogenetic lines within the genus Lamium. The study showed also that the rpo genes were reliable phylogenetic markers, useful in the reconstruction of interconnections of species belonging to the same genus. Of the four tested genes, the most promising phylogenetic marker was rpoA gene, while the least useful gene appeared to be rpoC1.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-28</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611376</prism:doi>
	<prism:startingPage>11376</prism:startingPage>
		<prism:endingPage>11391</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[The Uneven Rate of the Molecular Evolution of Gene Sequences of DNA-Dependent RNA Polymerase I of the Genus Lamium L.]]></dc:title>
    <dc:date>2013-05-28</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611376</dc:identifier>
    	<dc:creator>Katarzyna Krawczyk</dc:creator>
		<dc:creator>Jakub Sawicki</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11356">
	<title><![CDATA[IJMS, Vol. 14, Pages 11356-11375: Characterization of the Pinus massoniana Transcriptional Response to Bursaphelenchus xylophilus Infection Using Suppression Subtractive Hybridization]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11356</link>
	<description>Pine wilt disease (PWD) caused by pine wood nematode (PWN), Bursaphelenchus xylophilus, is the most destructive diseases of pine and poses a threat of serious economic losses worldwide. Although several of the mechanisms involved in disease progression have been discovered, the molecular response of Pinus massoniana to PWN infection has not been explored. We constructed four subtractive suppression hybridization cDNA libraries by taking time-course samples from PWN-inoculated Masson pine trees. One-hundred forty-four significantly differentially expressed sequence tags (ESTs) were identified, and 124 high-quality sequences with transcriptional features were selected for gene ontology (GO) and individual gene analyses. There were marked differences in the types of transcripts, as well as in the timing and levels of transcript expression in the pine trees following PWN inoculation. Genes involved in signal transduction, transcription and translation and secondary metabolism were highly expressed after 24 h and 72 h, while stress response genes were highly expressed only after 72 h. Certain transcripts responding to PWN infection were discriminative; pathogenesis and cell wall-related genes were more abundant, while detoxification or redox process-related genes were less abundant. This study provides new insights into the molecular mechanisms that control the biochemical and physiological responses of pine trees to PWN infection, particularly during the initial stage of infection.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-28</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611356</prism:doi>
	<prism:startingPage>11356</prism:startingPage>
		<prism:endingPage>11375</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Characterization of the Pinus massoniana Transcriptional Response to Bursaphelenchus xylophilus Infection Using Suppression Subtractive Hybridization]]></dc:title>
    <dc:date>2013-05-28</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611356</dc:identifier>
    	<dc:creator>Liang Xu</dc:creator>
		<dc:creator>Zhen-Yu Liu</dc:creator>
		<dc:creator>Kai Zhang</dc:creator>
		<dc:creator>Quan Lu</dc:creator>
		<dc:creator>Jun Liang</dc:creator>
		<dc:creator>Xing-Yao Zhang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11347">
	<title><![CDATA[IJMS, Vol. 14, Pages 11347-11355: Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11347</link>
	<description>PCA3 (prostate cancer gene 3) and multiparametric 3 tesla MRI are new promising diagnostic tools in the detection of PCa. Our aim was to study the clinical value of the Progensa PCA3-test: its predictive value for biopsy outcome, Gleason score and MRI outcome. We evaluated, retrospectively, 591 patients who underwent a Progensa PCA3-test at the Radboud University Nijmegen Medical Centre between May 2006 and December 2009. Prostate biopsies were performed in 290 patients; a multiparametric 3 tesla MRI of the prostate was performed in 163/591 patients. The PCA3-score was correlated to biopsy results and MRI outcome. The results show that PCA3 was highly predictive for biopsy outcome (p &amp;amp;lt; 0.001); there was no correlation with the Gleason score upon biopsy (p = 0.194). The PCA3-score of patients with a suspicious region for PCa on MRI was significantly higher (p &amp;amp;lt; 0.001) than in patients with no suspicious region on MRI (52 vs. 21). In conclusion, PCA3 is a valuable diagnostic biomarker for PCa; it did not correlate with the Gleason score. Furthermore, multiparametric MRI outcome was significantly correlated with the PCA3-score. Thus, PCA3 could be used to select patients that require MRI. However, in patients with a negative PCA3 and high clinical suspicion of PCa, a multiparametric MRI should also be done.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-28</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611347</prism:doi>
	<prism:startingPage>11347</prism:startingPage>
		<prism:endingPage>11355</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI]]></dc:title>
    <dc:date>2013-05-28</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611347</dc:identifier>
    	<dc:creator>Gisele Leyten</dc:creator>
		<dc:creator>Elisabeth Wierenga</dc:creator>
		<dc:creator>J. Sedelaar</dc:creator>
		<dc:creator>Inge van Oort</dc:creator>
		<dc:creator>Jurgen Futterer</dc:creator>
		<dc:creator>Jelle Barentsz</dc:creator>
		<dc:creator>Jack Schalken</dc:creator>
		<dc:creator>Peter Mulders</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11319">
	<title><![CDATA[IJMS, Vol. 14, Pages 11319-11346: Danger Control Programs Cause Tissue Injury and Remodeling]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11319</link>
	<description>Are there common pathways underlying the broad spectrum of tissue pathologies that develop upon injuries and from subsequent tissue remodeling? Here, we explain the pathophysiological impact of a set of evolutionary conserved danger control programs for tissue pathology. These programs date back to the survival benefits of the first multicellular organisms upon traumatic injuries by launching a series of danger control responses, i.e.,  1. Haemostasis, or clotting to control bleeding; 2. Host defense, to control pathogen entry and spreading; 3. Re-epithelialisation, to recover barrier functions; and 4. Mesenchymal, to repair to regain tissue stability. Taking kidney pathology as an example, we discuss how clotting, inflammation, epithelial healing, and fibrosis/sclerosis determine the spectrum of kidney pathology, especially when they are insufficiently activated or present in an overshooting and deregulated manner. Understanding the evolutionary benefits of these response programs may refine the search for novel therapeutic targets to limit organ dysfunction in acute injuries and in progressive chronic tissue remodeling</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-28</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611319</prism:doi>
	<prism:startingPage>11319</prism:startingPage>
		<prism:endingPage>11346</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Danger Control Programs Cause Tissue Injury and Remodeling]]></dc:title>
    <dc:date>2013-05-28</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611319</dc:identifier>
    	<dc:creator>Jan Hagemann</dc:creator>
		<dc:creator>Holger Haegele</dc:creator>
		<dc:creator>Susanna Müller</dc:creator>
		<dc:creator>Hans-Joachim Anders</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11302">
	<title><![CDATA[IJMS, Vol. 14, Pages 11302-11318: A High Molecular-Mass Anoxybacillus sp. SK3-4 Amylopullulanase: Characterization and Its Relationship in  Carbohydrate Utilization]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11302</link>
	<description>An amylopullulanase of the thermophilic Anoxybacillus sp. SK3-4 (ApuASK) was purified to homogeneity and characterized. Though amylopullulanases larger than  200 kDa are rare, the molecular mass of purified ApuASK appears to be approximately 225 kDa, on both SDS-PAGE analyses and native-PAGE analyses. ApuASK was stable between pH 6.0 and pH 8.0 and exhibited optimal activity at pH 7.5. The optimal temperature for ApuASK enzyme activity was 60 °C, and it retained 54% of its total activity for 240 min at 65 °C. ApuASK reacts with pullulan, starch, glycogen, and dextrin, yielding glucose, maltose, and maltotriose. Interestingly, most of the previously described amylopullulanases are unable to produce glucose and maltose from these substrates. Thus, ApuASK is a novel, high molecular-mass amylopullulanase able to produce glucose, maltose, and maltotriose from pullulan and starch. Based on whole genome sequencing data, ApuASK appeared to be the largest protein present in Anoxybacillus sp. SK3-4. The α-amylase catalytic domain present in all of the amylase superfamily members is present in ApuASK, located between the cyclodextrin (CD)-pullulan-degrading N-terminus and the α-amylase catalytic C-terminus (amyC) domains. In addition, the existence of a S-layer homology (SLH) domain indicates that ApuASK might function as a cell-anchoring enzyme and be important for carbohydrate utilization in a streaming hot spring.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-28</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611302</prism:doi>
	<prism:startingPage>11302</prism:startingPage>
		<prism:endingPage>11318</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[A High Molecular-Mass Anoxybacillus sp. SK3-4 Amylopullulanase: Characterization and Its Relationship in  Carbohydrate Utilization]]></dc:title>
    <dc:date>2013-05-28</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611302</dc:identifier>
    	<dc:creator>Ummirul Kahar</dc:creator>
		<dc:creator>Kok-Gan Chan</dc:creator>
		<dc:creator>Madihah Salleh</dc:creator>
		<dc:creator>Siew Hii</dc:creator>
		<dc:creator>Kian Goh</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11277">
	<title><![CDATA[IJMS, Vol. 14, Pages 11277-11301: Current Status and Future Perspectives of Mass  Spectrometry Imaging]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11277</link>
	<description>Mass spectrometry imaging is employed for mapping proteins, lipids and metabolites in biological tissues in a morphological context. Although initially developed as a tool for biomarker discovery by imaging the distribution of protein/peptide in tissue sections, the high sensitivity and molecular specificity of this technique have enabled its application to biomolecules, other than proteins, even in cells, latent finger prints and  whole organisms. Relatively simple, with no requirement for labelling, homogenization, extraction or reconstitution, the technique has found a variety of applications in molecular biology, pathology, pharmacology and toxicology. By discriminating the spatial distribution of biomolecules in serial sections of tissues, biomarkers of lesions and the biological responses to stressors or diseases can be better understood in the context of structure and function. In this review, we have discussed the advances in the different aspects of mass spectrometry imaging processes, application towards different disciplines and relevance to the field of toxicology.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-28</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611277</prism:doi>
	<prism:startingPage>11277</prism:startingPage>
		<prism:endingPage>11301</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Current Status and Future Perspectives of Mass  Spectrometry Imaging]]></dc:title>
    <dc:date>2013-05-28</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611277</dc:identifier>
    	<dc:creator>Surendra Nimesh</dc:creator>
		<dc:creator>Susantha Mohottalage</dc:creator>
		<dc:creator>Renaud Vincent</dc:creator>
		<dc:creator>Prem Kumarathasan</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11259">
	<title><![CDATA[IJMS, Vol. 14, Pages 11259-11276: New Evidence for Cross Talk between Melatonin and Mitochondria Mediated by a Circadian-Compatible  Interaction with Nitric Oxide]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11259</link>
	<description>Extending our previous observations, we have shown on HaCat cells that melatonin, at ~10−9 M concentration, transiently raises not only the expression of the neuronal nitric oxide synthase (nNOS) mRNA, but also the nNOS protein synthesis and the nitric oxide oxidation products, nitrite and nitrate. Interestingly, from the cell bioenergetic point of view, the activated NO-related chemistry induces a mild decrease of the oxidative phosphorylation (OXPHOS) efficiency, paralleled by a depression of the mitochondrial membrane potential. The OXPHOS depression is apparently balanced by glycolysis.  The mitochondrial effects described have been detected only at nanomolar concentration of melatonin and within a time window of a few hours’ incubation; both findings compatible with the melatonin circadian cycle.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-28</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611259</prism:doi>
	<prism:startingPage>11259</prism:startingPage>
		<prism:endingPage>11276</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[New Evidence for Cross Talk between Melatonin and Mitochondria Mediated by a Circadian-Compatible  Interaction with Nitric Oxide]]></dc:title>
    <dc:date>2013-05-28</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611259</dc:identifier>
    	<dc:creator>Paolo Sarti</dc:creator>
		<dc:creator>Maria Magnifico</dc:creator>
		<dc:creator>Fabio Altieri</dc:creator>
		<dc:creator>Daniela Mastronicola</dc:creator>
		<dc:creator>Marzia Arese</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11238">
	<title><![CDATA[IJMS, Vol. 14, Pages 11238-11258: Astrocytic Vesicle Mobility in Health and Disease]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11238</link>
	<description>Astrocytes are no longer considered subservient to neurons, and are, instead, now understood to play an active role in brain signaling. The intercellular communication of astrocytes with neurons and other non-neuronal cells involves the exchange of molecules by exocytotic and endocytotic processes through the trafficking of intracellular vesicles. Recent studies of single vesicle mobility in astrocytes have prompted new views of how astrocytes contribute to information processing in nervous tissue. Here, we review the trafficking of several types of membrane-bound vesicles that are specifically involved in the processes of (i) intercellular communication by gliotransmitters (glutamate, adenosine 5&#039;-triphosphate, atrial natriuretic peptide), (ii) plasma membrane exchange of transporters and receptors (EAAT2, MHC-II), and (iii) the involvement of vesicle mobility carrying aquaporins (AQP4) in water homeostasis. The properties of vesicle traffic in astrocytes are discussed in respect to networking with neighboring cells in physiologic and pathologic conditions, such as amyotrophic lateral sclerosis, multiple sclerosis, and states in which astrocytes contribute to neuroinflammatory conditions.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-27</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611238</prism:doi>
	<prism:startingPage>11238</prism:startingPage>
		<prism:endingPage>11258</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Astrocytic Vesicle Mobility in Health and Disease]]></dc:title>
    <dc:date>2013-05-27</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611238</dc:identifier>
    	<dc:creator>Maja Potokar</dc:creator>
		<dc:creator>Nina Vardjan</dc:creator>
		<dc:creator>Matjaž Stenovec</dc:creator>
		<dc:creator>Mateja Gabrijel</dc:creator>
		<dc:creator>Saša Trkov</dc:creator>
		<dc:creator>Jernej Jorgačevski</dc:creator>
		<dc:creator>Marko Kreft</dc:creator>
		<dc:creator>Robert Zorec</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11224">
	<title><![CDATA[IJMS, Vol. 14, Pages 11224-11237: Cisplatin Protects against Acute Liver Failure by Inhibiting Nuclear HMGB1 Release]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11224</link>
	<description>Cisplatin is one of the most widely used chemical drugs for anticancer  treatment. Recent studies have focused on the ability of cisplatin to retain the high mobility group box 1 (HMGB1) protein in cisplatin-DNA adducts, thereby preventing its release from the nucleus. Because HMGB1 is a powerful inflammatory mediator in many diseases, the aim of this study is to evaluate the therapeutic effect of cisplatin acute liver failure. In this study, low-dose cisplatin was administered to treat PMA-induced macrophage-like cells induced by PMA and rats with acute liver failure. We found that cell viability and liver injury were greatly improved by cisplatin treatment. The extracellular levels of HMGB1, TNF-α and IFN-γ were also significantly decreased by the administration of cisplatin. During inflammation, nuclear HMGB1 translocates from the nucleus to the cytoplasm. The administration of cisplatin reduced the cytoplasmic levels of HMGB1 and increased nuclear HMGB1 levels in vitro and in vivo. In conclusion, cisplatin can protect against acute liver failure by retaining HMGB1 in the nucleus and preventing its release into the extracellular milieu.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-27</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611224</prism:doi>
	<prism:startingPage>11224</prism:startingPage>
		<prism:endingPage>11237</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Cisplatin Protects against Acute Liver Failure by Inhibiting Nuclear HMGB1 Release]]></dc:title>
    <dc:date>2013-05-27</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611224</dc:identifier>
    	<dc:creator>Xun Li</dc:creator>
		<dc:creator>Li-Kun Wang</dc:creator>
		<dc:creator>Lu-Wen Wang</dc:creator>
		<dc:creator>Xiao-Qun Han</dc:creator>
		<dc:creator>Fan Yang</dc:creator>
		<dc:creator>Zuo-Jiong Gong</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11208">
	<title><![CDATA[IJMS, Vol. 14, Pages 11208-11223: Melatonin Receptor Genes in Vertebrates]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11208</link>
	<description>Melatonin receptors are members of the G protein-coupled receptor (GPCR) family. Three genes for melatonin receptors have been cloned. The MT1 (or Mel1a or MTNR1A) and MT2 (or Mel1b or MTNR1B) receptor subtypes are present in humans and other mammals, while an additional melatonin receptor subtype, Mel1c (or MTNR1C), has been identified in fish, amphibians and birds. Another melatonin related orphan receptor, GPR50, which does not bind melatonin, is found exclusively in mammals. The hormone melatonin is secreted primarily by the pineal gland, with highest levels occurring during the dark period of a circadian cycle. This hormone acts systemically in numerous organs. In the brain, it is involved in the regulation of various neural and endocrine processes, and it readjusts the circadian pacemaker, the suprachiasmatic nucleus. This article reviews recent studies of gene organization, expression, evolution and mutations of melatonin receptor genes of vertebrates. Gene polymorphisms reveal that numerous mutations are associated with diseases and disorders. The phylogenetic analysis of receptor genes indicates that GPR50 is an outgroup to all other melatonin receptor sequences. GPR50 may have separated from a melatonin receptor ancestor before the split between MTNR1C and the MTNR1A/B ancestor.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-27</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611208</prism:doi>
	<prism:startingPage>11208</prism:startingPage>
		<prism:endingPage>11223</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Melatonin Receptor Genes in Vertebrates]]></dc:title>
    <dc:date>2013-05-27</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611208</dc:identifier>
    	<dc:creator>Di Li</dc:creator>
		<dc:creator>David Smith</dc:creator>
		<dc:creator>Rüdiger Hardeland</dc:creator>
		<dc:creator>Ming Yang</dc:creator>
		<dc:creator>Huai Xu</dc:creator>
		<dc:creator>Long Zhang</dc:creator>
		<dc:creator>Hua Yin</dc:creator>
		<dc:creator>Qing Zhu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11190">
	<title><![CDATA[IJMS, Vol. 14, Pages 11190-11207: Angiotensin II Regulates microRNA-132/-212 in Hypertensive Rats and Humans]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11190</link>
	<description>MicroRNAs (miRNAs), a group of small non-coding RNAs that fine tune translation of multiple target mRNAs, are emerging as key regulators in cardiovascular development and disease. MiRNAs are involved in cardiac hypertrophy, heart failure and remodeling following cardiac infarction; however, miRNAs involved in hypertension have not been thoroughly investigated. We have recently reported that specific miRNAs play an integral role in Angiotensin II receptor (AT1R) signaling, especially after activation of the Gαq signaling pathway. Since AT1R blockers are widely used to treat hypertension, we undertook a detailed analysis of potential miRNAs involved in Angiotensin II (AngII) mediated hypertension in rats and hypertensive patients, using miRNA microarray and qPCR analysis. The miR-132 and miR-212 are highly increased in the heart, aortic wall and kidney of rats with hypertension (159 ± 12 mm Hg) and cardiac hypertrophy following chronic AngII infusion. In addition, activation of the endothelin receptor, another Gαq coupled receptor, also increased miR-132 and miR-212. We sought to extend these observations using human samples by reasoning that AT1R blockers may decrease  miR-132 and miR-212. We analyzed tissue samples of mammary artery obtained from surplus arterial tissue after coronary bypass operations. Indeed, we found a decrease in expression levels of miR-132 and miR-212 in human arteries from bypass-operated patients treated with AT1R blockers, whereas treatment with β-blockers had no effect. Taken together, these data suggest that miR-132 and miR-212 are involved in AngII induced hypertension, providing a new perspective in hypertensive disease mechanisms.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-27</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611190</prism:doi>
	<prism:startingPage>11190</prism:startingPage>
		<prism:endingPage>11207</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Angiotensin II Regulates microRNA-132/-212 in Hypertensive Rats and Humans]]></dc:title>
    <dc:date>2013-05-27</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611190</dc:identifier>
    	<dc:creator>Tilde Eskildsen</dc:creator>
		<dc:creator>Pia Jeppesen</dc:creator>
		<dc:creator>Mikael Schneider</dc:creator>
		<dc:creator>Anne Nossent</dc:creator>
		<dc:creator>Maria Sandberg</dc:creator>
		<dc:creator>Pernille Hansen</dc:creator>
		<dc:creator>Charlotte Jensen</dc:creator>
		<dc:creator>Maria Hansen</dc:creator>
		<dc:creator>Niels Marcussen</dc:creator>
		<dc:creator>Lars Rasmussen</dc:creator>
		<dc:creator>Peter Bie</dc:creator>
		<dc:creator>Ditte Andersen</dc:creator>
		<dc:creator>Søren Sheikh</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11171">
	<title><![CDATA[IJMS, Vol. 14, Pages 11171-11189: Fluctuation of Global Gene Expression by Endogenous miRNA Response to the Introduction of an Exogenous miRNA]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11171</link>
	<description>Most of the intracellular endogenous microRNAs (endo-miRNAs) are considered to be saturated in Argonaute (Ago) proteins in the RNA-induced silencing complexes (RISCs). When exogenous miRNAs (exo-miRNAs) are introduced into cells, endo-miRNAs in the RISC may be replaced with exo-miRNAs or exo-miRNAs, and  endo-miRNAs might also compete for the position in the newly synthesized RISC with each other. This would lead to the fluctuation of global gene expression not only by repression of exo-miRNA target gene expression, but also by the increase of the  endo-miRNA target gene expression. In the present study, we quantified the changes in the expression levels of target genes of exo-miRNA and endo-miRNA in the cells transfected with fifteen different exo-miRNAs by microarray experiments. Different exo-miRNAs increased ratios of expression levels of target genes of a given endo-miRNA to different extents, suggesting that the replacement efficiencies might differ according to the  exo-miRNA types. However, the increased ratios in the expression levels of each  endo-miRNA target genes by the transfection of any particular exo-miRNA were mostly equivalent, suggesting that the endo-miRNAs present in the RISC might be replaced with excessive exo-miRNAs at similar levels, probably because they exist in single-stranded forms in the RISC.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-27</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611171</prism:doi>
	<prism:startingPage>11171</prism:startingPage>
		<prism:endingPage>11189</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Fluctuation of Global Gene Expression by Endogenous miRNA Response to the Introduction of an Exogenous miRNA]]></dc:title>
    <dc:date>2013-05-27</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611171</dc:identifier>
    	<dc:creator>Yoshiro Nagata</dc:creator>
		<dc:creator>Eigo Shimizu</dc:creator>
		<dc:creator>Naoki Hibio</dc:creator>
		<dc:creator>Kumiko Ui-Tei</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11157">
	<title><![CDATA[IJMS, Vol. 14, Pages 11157-11170: Isolation and Enhancement of a Homogenous in Vitro Human Hertwig’s Epithelial Root Sheath Cell Population]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11157</link>
	<description>Hertwig’s epithelial root sheath (HERS) cells play a pivotal role during root formation of the tooth and are able to form cementum-like tissue. The aim of the present study was to establish a HERS cell line for molecular and biochemical studies using a selective digestion method. Selective digestion was performed by the application  of trypsin-EDTA for 2 min, which led to the detachment of fibroblast-like-cells, with  the rounded cells attached to the culture plate. The HERS cells displayed a typical cuboidal/squamous-shaped appearance. Characterization of the HERS cells using immunofluorescence staining and flow cytometry analysis showed that these cells expressed pan-cytokeratin, E-cadherin, and p63 as epithelial markers. Moreover, RT-PCR confirmed that these cells expressed epithelial-related genes, such as cytokeratin 14,  E-cadherin, and ΔNp63. Additionally, HERS cells showed low expression of CD44 and CD105 with absence of CD34 and amelogenin expressions. In conclusion, HERS cells have been successfully isolated using a selective digestion method, thus enabling future studies on the roles of these cells in the formation of cementum-like tissue in vitro.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-27</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611157</prism:doi>
	<prism:startingPage>11157</prism:startingPage>
		<prism:endingPage>11170</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Isolation and Enhancement of a Homogenous in Vitro Human Hertwig’s Epithelial Root Sheath Cell Population]]></dc:title>
    <dc:date>2013-05-27</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611157</dc:identifier>
    	<dc:creator>Manal Farea</dc:creator>
		<dc:creator>Ahmad Halim</dc:creator>
		<dc:creator>Nurul Abdullah</dc:creator>
		<dc:creator>Chin Lim</dc:creator>
		<dc:creator>Khairani Mokhtar</dc:creator>
		<dc:creator>Zurairah Berahim</dc:creator>
		<dc:creator>Kasmawati Mokhtar</dc:creator>
		<dc:creator>Abdul Rani</dc:creator>
		<dc:creator>Adam Husein</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11145">
	<title><![CDATA[IJMS, Vol. 14, Pages 11145-11156: Prognostic Value of Tumor Markers, NSE, CA125 and SCC,  in Operable NSCLC Patients]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11145</link>
	<description>The aim of this study was to investigate the prognostic value of tumor markers in operable non-small cell lung cancer (NSCLC) patients. A total of 481 NSCLC patients were enrolled in the present study. High levels of neuron-specific enolase (NSE), carbohydrate antigen 125 (CA125) and squamous cell carcinoma antigen (SCC) were detected in 306 (63.6%), 89 (18.5%) and 125 (26.0%) patients, respectively. Seventy-eight of 481 patients died of disease progression, and the median disease-free survival (DFS) and overall survival (OS) were 16.0 and 21.0 months, respectively. The three-year DFS rate was 56.7%, and the OS rate was 75.3%. For serum NSE, the three-year cumulative DFS rate for the normal and elevated group was 67.7% and 51.8% (p = 0.007). The OS in patients with high and normal levels of NSE was 34.0 months and 48.0 months, respectively. The median DFS was 46.0 months versus 32.0 months (p = 0.001), and the OS was 48.0 months versus 44.0 months  (p = 0.001) in patients with normal and high levels of CA125. For patients with squamous cell carcinoma, the overall survival was significantly shorter in patients with elevated levels of SCC (p = 0.041). In the multivariate analysis high levels of NSE, CA125 and clinical stage were signiﬁcantly correlated with worse prognosis (p &amp;amp;lt; 0.05). Patients with all three tumor markers elevated presented the worst prognosis (p &amp;amp;lt; 0.05). In our analysis, high levels of preoperative serum NSE and CA125 are correlated with worse survival in operable  NSCLC patients.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-27</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611145</prism:doi>
	<prism:startingPage>11145</prism:startingPage>
		<prism:endingPage>11156</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Prognostic Value of Tumor Markers, NSE, CA125 and SCC,  in Operable NSCLC Patients]]></dc:title>
    <dc:date>2013-05-27</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611145</dc:identifier>
    	<dc:creator>Dangfan Yu</dc:creator>
		<dc:creator>Kaiqi Du</dc:creator>
		<dc:creator>Taifeng Liu</dc:creator>
		<dc:creator>Guojun Chen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11125">
	<title><![CDATA[IJMS, Vol. 14, Pages 11125-11144: Short-Term Chromium-Stress-Induced Alterations in the Maize Leaf Proteome]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11125</link>
	<description>Soil contamination by chromium (Cr) has become an increasing problem worldwide as a result of extensive industrial activities. Chromium, especially hexavalent Cr, impairs the growth and productivity of plants. Although it has been proposed that plants could modify their metabolism to adapt to Cr stress by reprogramming the expression of genes, especially those related to the antioxidant system, damage response, and electron transport chain, evidence at the protein expression level is lacking. To better understand the precise mechanisms underlying Cr phytoxicity and the plant response to Cr exposure, the time-course of changes in the protein expression profile induced by  short-term hexavalent Cr exposure (1, 6 and 24 h) were analyzed in maize leaves. Among the over 1200 protein spots detected reproducibly by two-dimensional electrophoresis  (2-DE), 60 were found to be differentially accumulated during Cr stress treatment. Of the  Cr-regulated proteins, 58 were identified using tandem mass spectrometry (MS/MS). The Cr-regulated proteins identified were mainly involved in ROS detoxification and defense responses (26%), photosynthesis and chloroplast organization (22%), post-transcriptional processing of mRNA and rRNA (12%), protein synthesis and folding (10%), the DNA damage response (5%), and the cytoskeleton (3%). The possible involvement of these Cr stress-responsive proteins in Cr phytoxicity and the plant response to Cr exposure in maize is discussed, taking into consideration the information available from other plant models. Our results provide preliminary evidence that will facilitate understanding the molecular mechanisms underlying Cr toxicity in maize.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-27</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611125</prism:doi>
	<prism:startingPage>11125</prism:startingPage>
		<prism:endingPage>11144</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Short-Term Chromium-Stress-Induced Alterations in the Maize Leaf Proteome]]></dc:title>
    <dc:date>2013-05-27</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611125</dc:identifier>
    	<dc:creator>Rong Wang</dc:creator>
		<dc:creator>Fei Gao</dc:creator>
		<dc:creator>Bing-Qian Guo</dc:creator>
		<dc:creator>Ji-Chang Huang</dc:creator>
		<dc:creator>Lei Wang</dc:creator>
		<dc:creator>Yi-Jun Zhou</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11113">
	<title><![CDATA[IJMS, Vol. 14, Pages 11113-11124: The Interaction of CuS and Halothiobacillus HT1 Biofilm in Microscale Using Synchrotron Radiation-Based Techniques]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11113</link>
	<description>In order to investigate the microbe-mineral interaction in the micro scale, spatial distribution and speciation of Cu and S in Halothiobacillus HT1 biofilm formed on a CuS surface was examined using synchrotron-based X-ray techniques. Confocal laser scanning microscope (CLSM) results indicated that Halothiobacillus HT1 biofilm formation gave rise to distinct chemical and redox gradients, leading to diverse niches in the biofilm. Live cells were distributed at the air-biofilm and membrane-biofilm interface. CuS was oxidized by Halothiobacillus HT1 biofilm, and copper penetrated into the biofilm. Sulfide was oxidized to cysteine (77.3%), sulfite (3.8%) and sulfonate (18.9%). Cu-cysteine-like species were involved in the copper homeostasis. These results significantly improve our understanding of the interfacial properties of the biofilm-mineral interface.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611113</prism:doi>
	<prism:startingPage>11113</prism:startingPage>
		<prism:endingPage>11124</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[The Interaction of CuS and Halothiobacillus HT1 Biofilm in Microscale Using Synchrotron Radiation-Based Techniques]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611113</dc:identifier>
    	<dc:creator>Huirong Lin</dc:creator>
		<dc:creator>Guangcun Chen</dc:creator>
		<dc:creator>Shenhai Zhu</dc:creator>
		<dc:creator>Yingxu Chen</dc:creator>
		<dc:creator>Dongliang Chen</dc:creator>
		<dc:creator>Wei Xu</dc:creator>
		<dc:creator>Xiaohan Yu</dc:creator>
		<dc:creator>Jiyan Shi</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11096">
	<title><![CDATA[IJMS, Vol. 14, Pages 11096-11112: Early Exercise Protects the Blood-Brain Barrier from Ischemic Brain Injury via the Regulation of MMP-9 and Occludin in Rats]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11096</link>
	<description>Early exercise within 24 h after stroke can reduce neurological deficits after ischemic brain injury. However, the mechanisms underlying this neuroprotection remain poorly understood. Ischemic brain injury disrupts the blood-brain barrier (BBB) and then triggers a cascade of events, leading to secondary brain injury and poor long-term outcomes. This study verified the hypothesis that early exercise protected the BBB after ischemia. Adult rats were randomly assigned to sham, early exercise (EE) or non-exercise (NE) groups. The EE and NE groups were subjected to ischemia induced by middle cerebral artery occlusion (MCAO). The EE group ran on a treadmill beginning 24 h after ischemia, 30 min per day for three days. After three-days’ exercise, EB extravasation and electron microscopy were used to evaluate the integrity of the BBB. Neurological deficits, cerebral infarct volume and the expression of MMP-9, the tissue inhibitors of metalloproteinase-1 (TIMP-1), and occludin were determined. The data indicated that early exercise significantly inhibited the ischemia-induced reduction of occludin, and an increase in MMP-9 promoted TIMP-1 expression (p &amp;amp;lt; 0.01), attenuated the BBB disruption (p &amp;amp;lt; 0.05) and neurological deficits (p &amp;amp;lt; 0.01) and diminished the infarct volume (p &amp;amp;lt; 0.01). Our results suggest that the neuroprotection conferred by early exercise was likely achieved by improving the function of the BBB via the regulation of MMP-9 and occludin.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611096</prism:doi>
	<prism:startingPage>11096</prism:startingPage>
		<prism:endingPage>11112</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Early Exercise Protects the Blood-Brain Barrier from Ischemic Brain Injury via the Regulation of MMP-9 and Occludin in Rats]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611096</dc:identifier>
    	<dc:creator>Yuling Zhang</dc:creator>
		<dc:creator>Pengyue Zhang</dc:creator>
		<dc:creator>Xiafeng Shen</dc:creator>
		<dc:creator>Shan Tian</dc:creator>
		<dc:creator>Yi Wu</dc:creator>
		<dc:creator>Yulian Zhu</dc:creator>
		<dc:creator>Jie Jia</dc:creator>
		<dc:creator>Junfa Wu</dc:creator>
		<dc:creator>Yongshan Hu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11084">
	<title><![CDATA[IJMS, Vol. 14, Pages 11084-11095: Increased Susceptibility of Radiation-Induced Intestinal Apoptosis in SMP30 KO Mice]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11084</link>
	<description>Recently, senescence marker protein-30 (SMP30) knockout (KO) mice have been reported to be susceptible to apoptosis, however, the role of SMP30 has not been characterized in the small intestine. The aim of the present study is to investigate the role of SMP30 in the process of spontaneous and γ-radiation-induced apoptosis in mouse small intestine. Eight-week-old male wild-type (WT) mice and SMP30 KO mice were examined after exposure to 0, 1, 3, 5, and 9 Gy of γ-radiation. Apoptosis in the crypts of the small intestine increased in the 0 to 5 Gy radiated SMP30 KO and WT mice. Radiation-induced apoptosis and the BAX/Bcl-2 ratio in the SMP30 KO mice were significantly increased in comparison to each identically treated group of WT mice (p &amp;amp;lt; 0.05). The levels of spontaneous apoptosis in both WT and KO mice were similar (p &amp;amp;gt; 0.05), indicating that increased apoptosis of crypt cells of SMP30 KO by irradiation can be associated with SMP30 depletion. These results suggested that SMP30 might be involved in overriding the apoptotic homeostatic mechanism in response to DNA damage.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611084</prism:doi>
	<prism:startingPage>11084</prism:startingPage>
		<prism:endingPage>11095</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Increased Susceptibility of Radiation-Induced Intestinal Apoptosis in SMP30 KO Mice]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611084</dc:identifier>
    	<dc:creator>Moon-Jung Goo</dc:creator>
		<dc:creator>Jin-Kyu Park</dc:creator>
		<dc:creator>Il-Hwa Hong</dc:creator>
		<dc:creator>Ah-Young Kim</dc:creator>
		<dc:creator>Eun-Mi Lee</dc:creator>
		<dc:creator>Eun-Joo Lee</dc:creator>
		<dc:creator>Meeyul Hwang</dc:creator>
		<dc:creator>Kyu-Shik Jeong</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11072">
	<title><![CDATA[IJMS, Vol. 14, Pages 11072-11083: Construction of a Full-Length Enriched cDNA Library and Preliminary Analysis of Expressed Sequence Tags from  Bengal Tiger Panthera tigris tigris]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11072</link>
	<description>In this study, a full-length enriched cDNA library was successfully constructed from Bengal tiger, Panthera tigris tigris, the most well-known wild Animal. Total RNA was extracted from cultured Bengal tiger fibroblasts in vitro. The titers of primary and amplified libraries were 1.28 × 106 pfu/mL and 1.56 × 109 pfu/mL respectively. The percentage of recombinants from unamplified library was 90.2% and average length of exogenous inserts was 0.98 kb. A total of 212 individual ESTs with sizes ranging from 356 to 1108 bps were then analyzed. The BLASTX score revealed that 48.1% of the sequences were classified as a strong match, 45.3% as nominal and 6.6% as a weak match. Among the ESTs with known putative function, 26.4% ESTs were found to be related to all kinds of metabolisms, 19.3% ESTs to information storage and processing, 11.3% ESTs to posttranslational modification, protein turnover, chaperones, 11.3% ESTs to transport, 9.9% ESTs to signal transducer/cell communication, 9.0% ESTs to structure protein, 3.8% ESTs to cell cycle, and only 6.6% ESTs classified as novel genes. By EST sequencing, a full-length gene coding ferritin was identified and characterized. The recombinant plasmid pET32a-TAT-Ferritin was constructed, coded for the TAT-Ferritin fusion protein with two 6× His-tags in N and C-terminal. After BCA assay, the concentration of soluble Trx-TAT-Ferritin recombinant protein was 2.32 ± 0.12 mg/mL. These results demonstrated that the reliability and representativeness of the cDNA library attained to the requirements of a standard cDNA library. This library provided a useful platform for the functional genome and transcriptome research of Bengal tigers. </description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611072</prism:doi>
	<prism:startingPage>11072</prism:startingPage>
		<prism:endingPage>11083</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Construction of a Full-Length Enriched cDNA Library and Preliminary Analysis of Expressed Sequence Tags from  Bengal Tiger Panthera tigris tigris]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611072</dc:identifier>
    	<dc:creator>Changqing Liu</dc:creator>
		<dc:creator>Dan Liu</dc:creator>
		<dc:creator>Yu Guo</dc:creator>
		<dc:creator>Taofeng Lu</dc:creator>
		<dc:creator>Xiangchen Li</dc:creator>
		<dc:creator>Minghai Zhang</dc:creator>
		<dc:creator>Jianzhang Ma</dc:creator>
		<dc:creator>Yuehui Ma</dc:creator>
		<dc:creator>Weijun Guan</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11061">
	<title><![CDATA[IJMS, Vol. 14, Pages 11061-11071: Ubiquitin-Conjugating Enzyme 9 Promotes Epithelial Ovarian Cancer Cell Proliferation in Vitro]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11061</link>
	<description>Epithelial ovarian cancer (EOC) is one of the leading causes of cancer deaths in women worldwide. Ubiquitin-conjugating enzyme 9 (Ubc9), the sole conjugating enzyme for sumoylation, regulates protein function and plays an important role in  sumoylation-mediated cellular pathways. Although sumoylation plays a key role in DNA repair and tumorgenesis, whether Ubc9 is involved in EOC progression remains unknown. In the present study, we constructed Ubc-9 expressed recombined plasmid  pEGFP-N1-Ubc9. The mRNA levels of Ubc9 were confirmed in human ovarian  cell lines before and after transfection with pEGFP-N1-Ubc9 or small interfering  RNA (siRNA) targeted Ubc9 by real-time polymerase chain reaction (PCR). The  MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to observe the effect of Ubc9 on cell proliferation. The protein levels of Ubc9, and proliferation-related signals Akt and physphorylated Akt were determined by Western blot. Our results showed that proliferation of EOC cells increased significantly in Ubc9 overexpressing cells, but decreased in Ubc9 knockdown cells. The physphorylation of Akt showed similar trends. In addition, the inhibitor of PI3K/Akt signaling pathway, LY294002, dramatically inhibited the growth of Ubc9 overexpressing cells. Therefore, Ubc9 gene plays an important role in cell proliferation in EOC through PI3K/Akt  signaling pathway.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611061</prism:doi>
	<prism:startingPage>11061</prism:startingPage>
		<prism:endingPage>11071</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Ubiquitin-Conjugating Enzyme 9 Promotes Epithelial Ovarian Cancer Cell Proliferation in Vitro]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611061</dc:identifier>
    	<dc:creator>Mei Dong</dc:creator>
		<dc:creator>Xiaoyan Pang</dc:creator>
		<dc:creator>Yang Xu</dc:creator>
		<dc:creator>Fang Wen</dc:creator>
		<dc:creator>Yi Zhang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11034">
	<title><![CDATA[IJMS, Vol. 14, Pages 11034-11060: Current Status of Biomarkers for Prostate Cancer]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11034</link>
	<description>Prostate cancer (PCa) is a leading cause of cancer-related death of men globally. Since its introduction, there has been intense debate as to the effectiveness of the prostate specific antigen (PSA) test as a screening tool for PCa. It is now evident that the PSA test produces unacceptably high rates of false positive results and is not prognostic. Here we review the current status of molecular biomarkers that promise to be prognostic and  that might inform individual patient management. It highlights current efforts to  identify biomarkers obtained by minimally invasive methods and discusses current knowledge with regard to gene fusions, mRNA and microRNAs, immunology, and  cancer-associated microparticles.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140611034</prism:doi>
	<prism:startingPage>11034</prism:startingPage>
		<prism:endingPage>11060</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Current Status of Biomarkers for Prostate Cancer]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611034</dc:identifier>
    	<dc:creator>Vicki Velonas</dc:creator>
		<dc:creator>Henry Woo</dc:creator>
		<dc:creator>Cristobal Remedios</dc:creator>
		<dc:creator>Stephen Assinder</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11024">
	<title><![CDATA[IJMS, Vol. 14, Pages 11024-11033: Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11024</link>
	<description>Objective: The aim of this study was to analyze the correlation and clinical significance between the expression of Mucin-1 (MUC1) and the Lewis y antigen with chemoresistance in ovarian epithelial cancers. Methods: Ovarian cancer patients (n = 92) treated at our hospital from May 2005 to July 2009 were divided, according to their treatment and follow-up outcomes, into a resistant group (n = 37) or sensitive group  (n = 55). The expression of MUC1 and Lewis y antigen in ovarian cancer tissues was detected using immunohistochemistry and correlated with chemoresistance. Results: The positive rates of MUC1 and Lewis y antigen in the resistant group were both 91.89%, significantly higher than their positive rates in the sensitive group (65.45% and 69.09%, respectively, and both p &amp;amp;lt; 0.05). MUC1 or Lewis y expression and the pathological stage of the tissue were independent risk factors for chemoresistance (all p &amp;amp;lt; 0.05). Conclusion: The increased expression of MUC1 and the Lewis y antigen is a significant risk factor for chemoresistance in patients with ovarian epithelial cancer.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611024</prism:doi>
	<prism:startingPage>11024</prism:startingPage>
		<prism:endingPage>11033</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611024</dc:identifier>
    	<dc:creator>Danye Zhang</dc:creator>
		<dc:creator>Jian Gao</dc:creator>
		<dc:creator>Liancheng Zhu</dc:creator>
		<dc:creator>Zhenhua Hu</dc:creator>
		<dc:creator>Rui Hou</dc:creator>
		<dc:creator>Shuice Liu</dc:creator>
		<dc:creator>Mingzi Tan</dc:creator>
		<dc:creator>Juanjuan Liu</dc:creator>
		<dc:creator>Bei Lin</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/11011">
	<title><![CDATA[IJMS, Vol. 14, Pages 11011-11023: Characterization and Antimicrobial Property of  Poly(Acrylic Acid) Nanogel Containing Silver Particle  Prepared by Electron Beam]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/11011</link>
	<description>In this study, we developed a one step process to synthesize nanogel containing silver nanoparticles involving electron beam irradiation. Water-soluble silver nitrate powder is dissolved in the distilled water and then poly(acrylic acid) (PAAc) and hexane are put into this silver nitrate solution. These samples are irradiated by an electron beam to make the PAAc nanogels containing silver nanoparticles (Ag/PAAc nanogels). The nanoparticles were characterized by scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS). In addition, the particle size and zeta-potential were confirmed by a particle size analyzer (PSA). The antibacterial properties of the nanogels were evaluated by paper diffusion test. The Ag/PAAc nanogels had an antibacterial effect against Escherichia coli and Staphylococcus aureus. The nanogels also demonstrated a good healing effect against diabetic ulcer. The size of the Ag/PAAc nanogels decreased with increasing irradiation doses, and the absolute value of the zeta potential increased with increasing irradiation doses. Also, the Ag/PAAc nanogels exhibited good antibacterial activity against both Gram-negative and Gram-positive bacteria. In in vivo wound healing, the Ag/PAAc nanogels have a good healing effect.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140611011</prism:doi>
	<prism:startingPage>11011</prism:startingPage>
		<prism:endingPage>11023</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Characterization and Antimicrobial Property of  Poly(Acrylic Acid) Nanogel Containing Silver Particle  Prepared by Electron Beam]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140611011</dc:identifier>
    	<dc:creator>Jong-Bae Choi</dc:creator>
		<dc:creator>Jong-Seok Park</dc:creator>
		<dc:creator>Myung-Seob Khil</dc:creator>
		<dc:creator>Hui-Jeong Gwon</dc:creator>
		<dc:creator>Youn-Mook Lim</dc:creator>
		<dc:creator>Sung-In Jeong</dc:creator>
		<dc:creator>Young-Min Shin</dc:creator>
		<dc:creator>Young-Chang Nho</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/10998">
	<title><![CDATA[IJMS, Vol. 14, Pages 10998-11010: Sod1 Loss Induces Intrinsic Superoxide Accumulation Leading to p53-Mediated Growth Arrest and Apoptosis]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/10998</link>
	<description>Oxidative damages induced by a redox imbalance cause age-related changes in cells and tissues. Superoxide dismutase (SOD) enzymes play a major role in the antioxidant system and they also catalyze superoxide radicals (O2·−). Since the loss of cytoplasmic SOD (SOD1) resulted in aging-like phenotypes in several types of mouse tissue, SOD1 is essential for the maintenance of tissue homeostasis. To clarify the cellular function of SOD1, we investigated the cellular phenotypes of Sod1-deficient fibroblasts. We demonstrated that Sod1 deficiency impaired proliferation and induced apoptosis associated with O2·− accumulation in the cytoplasm and mitochondria in fibroblasts.  Sod1 loss also decreased the mitochondrial membrane potential and led to DNA  damage-mediated p53 activation. Antioxidant treatments effectively improved the cellular phenotypes through suppression of both intracellular O2·− accumulation and p53 activation in Sod1-deficient fibroblasts. In vivo experiments revealed that transdermal treatment with a vitamin C derivative significantly reversed the skin thinning commonly associated with the upregulated p53 action in the skin. Our findings revealed that intrinsic O2·− accumulation promoted p53-mediated growth arrest and apoptosis as well as mitochondrial disfunction in the fibroblasts.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140610998</prism:doi>
	<prism:startingPage>10998</prism:startingPage>
		<prism:endingPage>11010</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Sod1 Loss Induces Intrinsic Superoxide Accumulation Leading to p53-Mediated Growth Arrest and Apoptosis]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140610998</dc:identifier>
    	<dc:creator>Kenji Watanabe</dc:creator>
		<dc:creator>Shuichi Shibuya</dc:creator>
		<dc:creator>Hirofumi Koyama</dc:creator>
		<dc:creator>Yusuke Ozawa</dc:creator>
		<dc:creator>Toshihiko Toda</dc:creator>
		<dc:creator>Koutaro Yokote</dc:creator>
		<dc:creator>Takahiko Shimizu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/10979">
	<title><![CDATA[IJMS, Vol. 14, Pages 10979-10997: Immune-Pineal Axis: Nuclear Factor κB (NF-kB) Mediates the Shift in the Melatonin Source from Pinealocytes to Immune Competent Cells]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/10979</link>
	<description>Pineal gland melatonin is the darkness hormone, while extra-pineal melatonin produced by the gonads, gut, retina, and immune competent cells acts as a paracrine or autocrine mediator. The well-known immunomodulatory effect of melatonin is observed either as an endocrine, a paracrine or an autocrine response. In mammals, nuclear translocation of nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) blocks noradrenaline-induced melatonin synthesis in pinealocytes, which induces melatonin synthesis in macrophages. In addition, melatonin reduces NF-κB activation in pinealocytes and immune competent cells. Therefore, pathogen- or danger-associated molecular patterns transiently switch the synthesis of melatonin from pinealocytes to immune competent cells, and as the response progresses melatonin inhibition of NF-κB activity leads these cells to a more quiescent state. The opposite effect of NF-κB in pinealocytes and immune competent cells is due to different NF-κB dimers recruited in each phase of the defense response. This coordinated shift of the source of melatonin driven by NF-κB is called the immune-pineal axis. Finally, we discuss how this concept might be relevant to a better understanding of pathological conditions with impaired melatonin rhythms and hope it opens new horizons for the research of side effects of melatonin-based therapies.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140610979</prism:doi>
	<prism:startingPage>10979</prism:startingPage>
		<prism:endingPage>10997</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Immune-Pineal Axis: Nuclear Factor κB (NF-kB) Mediates the Shift in the Melatonin Source from Pinealocytes to Immune Competent Cells]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140610979</dc:identifier>
    	<dc:creator>Regina Markus</dc:creator>
		<dc:creator>Erika Cecon</dc:creator>
		<dc:creator>Marco Pires-Lapa</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/10958">
	<title><![CDATA[IJMS, Vol. 14, Pages 10958-10978: Integrated -Omics: A Powerful Approach to Understanding the Heterogeneous Lignification of Fibre Crops]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/10958</link>
	<description>Lignin and cellulose represent the two main components of plant secondary walls and the most abundant polymers on Earth. Quantitatively one of the principal products of the phenylpropanoid pathway, lignin confers high mechanical strength and hydrophobicity to plant walls, thus enabling erect growth and high-pressure water transport in the vessels. Lignin is characterized by a high natural heterogeneity in its composition and abundance in plant secondary cell walls, even in the different tissues of the same plant. A typical example is the stem of fibre crops, which shows a lignified core enveloped by a cellulosic, lignin-poor cortex. Despite the great value of fibre crops for humanity, however, still little is known on the mechanisms controlling their cell wall biogenesis, and particularly, what regulates their spatially-defined lignification pattern. Given the chemical complexity and the heterogeneous composition of fibre crops’ secondary walls, only the use of multidisciplinary approaches can convey an integrated picture and provide exhaustive information covering different levels of biological complexity. The present review highlights the importance of combining high throughput -omics approaches to get a complete understanding of the factors regulating the lignification heterogeneity typical of fibre crops.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/ijms140610958</prism:doi>
	<prism:startingPage>10958</prism:startingPage>
		<prism:endingPage>10978</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Integrated -Omics: A Powerful Approach to Understanding the Heterogeneous Lignification of Fibre Crops]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140610958</dc:identifier>
    	<dc:creator>Gea Guerriero</dc:creator>
		<dc:creator>Kjell Sergeant</dc:creator>
		<dc:creator>Jean-François Hausman</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/1422-0067/14/6/10944">
	<title><![CDATA[IJMS, Vol. 14, Pages 10944-10957: Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal  Cell Carcinoma]]></title>
	<link>http://www.mdpi.com/1422-0067/14/6/10944</link>
	<description>In renal cell carcinoma (RCC), single members of the Wnt/β-catenin signaling cascade were recently identified to contribute to cancer progression. However, the role of Wnt1, one of the key ligands in β-catenin regulation, is currently unknown in RCC. Therefore, alterations of the Wnt1/β-catenin axis in clear cell RCC (ccRCC) were examined with regard to clinicopathology, overall survival (OS) and cancer specific survival (CSS). Corresponding ccRCCs and benign renal tissue were analyzed in 278 patients for Wnt1 and β-catenin expression by immunohistochemistry in tissue microarrays. Expression scores, including intensity and percentage of stained cells, were compared between normal kidney and ccRCCs. Data was categorized according to mean expression scores and correlated to tumor and patients’ characteristics. Survival was analyzed according to the Kaplan-Meier and log-rank test. Univariable and multivariable Cox proportional hazard regression models were used to explore the independent prognostic value of Wnt1 and β-catenin. In ccRCCs, high Wnt1 was associated with increased tumor diameter, stage and vascular invasion  (p ≤ 0.02). High membranous β-catenin was associated with advanced stage, vascular invasion and tumor necrosis (p ≤ 0.01). Higher diameter, stage, node involvement, grade, vascular invasion and sarcomatoid differentiation (p ≤ 0.01) were found in patients with high cytoplasmic β-catenin. Patients with a high cytoplasmic β-catenin had a significantly reduced OS (hazard ratio (HR) 1.75) and CSS (HR 2.26), which was not independently associated with OS and CSS after adjustment in the multivariable model. Increased ccRCC aggressiveness was reflected by an altered Wnt1/β-catenin signaling. Cytoplasmic β-catenin was identified as the most promising candidate associated with unfavorable clinicopathology and impaired survival. Nevertheless, the shift of membranous β-catenin to the cytoplasm with a subsequently increased nuclear expression, as shown for other malignancies, could not be demonstrated to be present in ccRCC.</description>

	<prism:publicationName>International Journal of Molecular Sciences</prism:publicationName>
	<prism:publicationDate>2013-05-24</prism:publicationDate>
	<prism:volume>14</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/ijms140610944</prism:doi>
	<prism:startingPage>10944</prism:startingPage>
		<prism:endingPage>10957</prism:endingPage>
		<prism:issn>1422-0067</prism:issn>
	
	<dc:title><![CDATA[Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal  Cell Carcinoma]]></dc:title>
    <dc:date>2013-05-24</dc:date>
	<dc:identifier>doi: 10.3390/ijms140610944</dc:identifier>
    	<dc:creator>Stephan Kruck</dc:creator>
		<dc:creator>Christian Eyrich</dc:creator>
		<dc:creator>Marcus Scharpf</dc:creator>
		<dc:creator>Karl-Dietrich Sievert</dc:creator>
		<dc:creator>Falco Fend</dc:creator>
		<dc:creator>Arnulf Stenzl</dc:creator>
		<dc:creator>Jens Bedke</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
    
<cc:License rdf:about="http://creativecommons.org/licenses/by/3.0/">
	<cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
